Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.4467851233933384e-50,41.75032258064516,4791.263291513638,"['RPL4', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",7.595621897815026e-48,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,7.934108631708141e-18,6.886188400938653,271.14615185947906,"['COX7B', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1']",2.082703515823387e-15,0,0,49
3,Oxidative phosphorylation WP623,2.0377467820317994e-10,6.44794952681388,143.87958604827247,"['NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'NDUFB2', 'ATP5MC3', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1']",3.566056868555649e-08,0,0,28
4,Nonalcoholic fatty liver disease WP4396,1.2226159978293278e-09,3.2592356687898087,66.88692420969068,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'COX4I1', 'COX6A1', 'COX7C', 'LEPR', 'UQCRFS1', 'RAC1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'PPARA', 'CEBPA', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'BCL2L11', 'CYC1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS']",1.6046834971509928e-07,0,0,49
5,Mitochondrial CIV Assembly WP4922,2.2064039014946908e-07,6.784464526052682,103.98366721123614,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",2.3167240965694254e-05,0,0,18
6,Mitochondrial complex I assembly model OXPHOS system WP4324,2.6277947520186136e-06,4.148571428571429,53.306510840976514,"['NDUFA8', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFAF3']",0.0002299320408016287,0,0,22
7,"GPCRs, Class A Rhodopsin-like WP455",1.4820567041599238e-05,3.0351063829787233,33.748849269393624,"['GPR27', 'CHRM1', 'GPR87', 'GPR22', 'PTGER3', 'CHRM5', 'HTR2B', 'OPRL1', 'GPR83', 'ADRA1D', 'MCHR1', 'LTB4R', 'GPR39', 'GPR12', 'SSTR1', 'GPR6', 'ADRA2C', 'HTR5A', 'SSTR3', 'HCRTR2', 'MAS1', 'LPAR6', 'FSHR', 'ACKR4', 'OR6A2', 'RGL4', 'OR3A2']",0.0011115425281199428,0,0,27
8,Myometrial relaxation and contraction pathways WP289,4.855615107191852e-05,2.350871903110709,23.3507161679727,"['RYR1', 'YWHAE', 'RGS14', 'YWHAB', 'ITPR2', 'RXFP1', 'ACTB', 'ACTG1', 'RGS4', 'RGS2', 'GNG3', 'YWHAQ', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'PRKCG', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP4', 'GSTO1', 'IGFBP3', 'PRKCD', 'FOS', 'GNG13', 'CREB3', 'ACTC1', 'PRKAR1A', 'GNB2', 'GNAS', 'PRKCQ', 'CALM3', 'PRKD1', 'CALM1', 'CALM2']",0.0031864974140946526,0,0,36
9,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0002966674321923765,1.582868553329202,12.857481077913054,"['YWHAE', 'ARPC5L', 'HSPB1', 'SHB', 'RPL10A', 'ELK1', 'RPL7', 'ACTG1', 'RND1', 'TUBB8', 'RPL18A', 'TMSB4X', 'CFL1', 'BSG', 'RPLP2', 'SH3BGRL3', 'RAC1', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'HRAS', 'HSP90AA1', 'SSR4', 'IGFBP3', 'PRKCD', 'RPS6', 'RPL13A', 'EPN1', 'VAV2', 'RCN1', 'RAB37', 'KATNAL2', 'FSCN1', 'RPL27', 'PRKD1', 'RPL26', 'PFN1', 'ATP6V0D1', 'ALDOA', 'DSC1', 'GAPDH', 'SLC25A11', 'PTMA', 'FJX1', 'ARF6', 'LRRC59', 'SET', 'EPB41', 'CRIP2', 'FOXO4', 'TXN', 'ACACB', 'NDRG1', 'FUT1', 'PPP2CA', 'PRDX2', 'STIP1', 'SDCBP', 'LDHA', 'FGD5', 'DNAJB4', 'AP2S1', 'PGK1', 'DNAJB9', 'FLNB', 'FADD', 'CCT7', 'MAPK3', 'EGR1', 'JUN', 'JAG1', 'SDF2L1', 'EGR3', 'NFATC2', 'DNAJA1', 'NFKBIA', 'NR4A1', 'NOX4', 'CYCS', 'HYOU1', 'CALR', 'EIF4G2', 'HSPA1A']",0.01730560021122196,0,0,84
10,Glycolysis and Gluconeogenesis WP534,0.0003579942840425914,4.025146137237348,31.939508588695396,"['TPI1', 'MDH2', 'PGAM1', 'ENO1', 'ENO2', 'LDHB', 'LDHA', 'PFKL', 'PKM', 'MPC2', 'PGK1', 'ALDOA', 'GAPDH']",0.01879469991223605,0,0,13
11,Computational Model of Aerobic Glycolysis WP4629,0.00048733379950515707,9.196875,70.14053049375947,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.02325911315820068,0,0,7
12,Calcium Regulation in the Cardiac Cell WP536,0.0006901952065067005,2.050071736011478,14.921521122575147,"['RYR1', 'YWHAE', 'GNAZ', 'CHRM1', 'RGS14', 'YWHAB', 'CHRM5', 'ITPR2', 'ADRA1D', 'RGS4', 'RGS2', 'GNG3', 'PLN', 'YWHAQ', 'GJA9', 'YWHAG', 'YWHAH', 'PRKCG', 'PRKCH', 'PRKCD', 'GNG13', 'FKBP1A', 'SLC8A3', 'PRKAR1A', 'GNB2', 'GNAS', 'PRKCQ', 'CALM3', 'PRKD1', 'CALR', 'CASQ1', 'CALM1', 'CALM2']",0.030196040284668147,0,0,33
13,Mitochondrial complex III assembly WP4921,0.0009541927765490951,6.007273655330824,41.778454699930776,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.03779126634824041,0,0,8
14,Galanin receptor pathway WP4970,0.0010077671026197444,7.356875,50.76257128489869,"['CDKN1A', 'CDKN1B', 'BCL2L11', 'PRKCD', 'PPARG', 'FOS', 'VAMP2']",0.03779126634824041,0,0,7
15,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.0011527685035285134,2.509034148010349,16.97509341933048,"['PSMD10', 'HSPA8', 'HSPA1L', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBB4B', 'TUBB4A', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBB6', 'PSMC5', 'TUBA1A', 'TUBB2A', 'PSMC3', 'PSMD2', 'STUB1', 'HSPA1B', 'HSPA1A']",0.04034689762349797,0,0,20
16,Proximal tubule transport WP4917,0.0014802908736545855,3.257343223771156,21.223274088280952,"['ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'SLC47A1', 'SLC3A1', 'SLC5A8', 'SLC7A9', 'CA4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.048572044291791086,0,0,13
17,HIF1A and PPARG regulation of glycolysis WP2456,0.0016612783821326033,13.128902765388046,84.02718155913279,"['LDHA', 'TPI1', 'GPAT3', 'PPARG', 'GAPDH']",0.05130418533056569,0,0,5
18,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.002867835171592458,20.998662505572895,122.93032446141628,"['COX8A', 'GSTP1', 'EPHX2', 'COX5A']",0.07924281395189688,0,0,4
19,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.002867835171592458,20.998662505572895,122.93032446141628,"['EPHX2', 'PPARG', 'PPARA', 'CYP2C18']",0.07924281395189688,0,0,4
20,Selenium Micronutrient Network WP15,0.00380299583258046,2.4767579824399504,13.800411629646009,"['GPX4', 'GPX3', 'TXN', 'KMO', 'SELENOK', 'SELENOH', 'SOD1', 'PRDX3', 'PRDX2', 'SELENOM', 'PRDX5', 'RFK', 'PRDX1', 'SELENOW', 'SEPHS2', 'MSRB1']",0.09507489581451149,0,0,16
21,Translation Factors WP107,0.00380299583258046,2.4767579824399504,13.800411629646009,"['EIF4A2', 'EIF5A', 'EIF1AX', 'EEF2', 'GSPT2', 'EIF1', 'EEF1B2', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF6', 'EIF3I', 'EEF1A2', 'EIF4H', 'EIF3G', 'EIF4B']",0.09507489581451149,0,0,16
22,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.004134314545910633,4.204019651630192,23.07348327050545,"['H3F3B', 'H2AFZ', 'H3F3A', 'H2AFX', 'H2AFV', 'DUSP6', 'MAPK3', 'EZH2']",0.09701131315276366,0,0,8
23,IL-18 signaling pathway WP4754,0.0042500194333591704,1.645341802782819,8.984934712639019,"['MTCH1', 'CEBPB', 'NRN1', 'STOML1', 'EPB41', 'CD81', 'MEPCE', 'COX17', 'HSPB1', 'ENO1', 'ACACB', 'FUT1', 'CENPB', 'PTMS', 'TMSB4X', 'STMN1', 'BSG', 'FADD', 'RPS11', 'MAPK3', 'SLC12A3', 'CPT1A', 'JUN', 'USP5', 'IMP3', 'ARG1', 'BAD', 'PRKCD', 'IL18', 'NDUFC1', 'FOS', 'TACR1', 'EEF2', 'NFKBIA', 'NR4A1', 'ARL4D', 'NACA', 'CYCS', 'NFKBIE', 'CDK5R2', 'ITM2C', 'ARF6', 'MYH7']",0.09701131315276366,0,0,43
24,Cellular Proteostasis WP4918,0.007508982073370205,10.498439589835042,51.354748346051736,"['VBP1', 'PFDN2', 'PFDN5', 'PFDN6']",0.1544694852364891,0,0,4
25,NRF2 pathway WP2884,0.007568188370573754,1.9227403791252713,9.39028245754567,"['EGR1', 'HSP90AA1', 'HSP90AB1', 'SRXN1', 'SLC6A16', 'GPX3', 'GSTP1', 'SLC2A12', 'SLC39A11', 'NRG1', 'TXN', 'SLC7A11', 'SLC5A3', 'SLC2A9', 'DNAJB1', 'SLC5A8', 'FTH1', 'PRDX1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'FTL', 'HSPA1A']",0.1544694852364891,0,0,23
26,Nuclear Receptors Meta-Pathway WP2882,0.007649917364092792,1.5692115174639005,7.646862557202812,"['CDKN1B', 'HSP90AB1', 'SRXN1', 'GSTP1', 'AMIGO2', 'TXN', 'SLC7A11', 'SLC5A3', 'CYP3A7', 'DNAJB1', 'RGS2', 'FTH1', 'PRDX1', 'ENC1', 'SLC39A7', 'JUNB', 'SLC39A1', 'SLC39A3', 'EGR1', 'ABCG8', 'CPT1A', 'JUN', 'HSP90AA1', 'JUND', 'GADD45B', 'SLC6A16', 'GPX3', 'PLK2', 'TSC22D3', 'SLC2A12', 'SLC39A11', 'AIP', 'NRG1', 'SLC2A9', 'SLC5A8', 'PSMC5', 'FASN', 'B3GNT5', 'BHLHE40', 'AHRR', 'PPARA', 'HSPA1A', 'FKBP5', 'FTL']",0.1544694852364891,0,0,44
27,Vitamin D Receptor Pathway WP2877,0.009282462654053357,1.98642729452432,9.29574157242648,"['CDKN2D', 'COLEC11', 'CEBPA', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'NFATC2', 'PRDM1', 'CEACAM1', 'BGLAP', 'CREG2', 'S100A6', 'TIMP2', 'SOSTDC1', 'PRKCQ', 'JUNB', 'FGF23']",0.17712908618822137,0,0,20
28,Pathogenic Escherichia coli infection WP2272,0.00944688459670514,2.4415526282133264,11.382689906318111,"['TUBB', 'ARPC5L', 'ARPC4', 'TUBB4B', 'TUBB4A', 'ACTB', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBB6', 'TUBA1A', 'TUBB2A', 'YWHAQ']",0.17712908618822137,0,0,13
29,Cori Cycle WP1946,0.010411731422548118,4.5014343086632245,20.548246756148945,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.18848824127026764,0,0,6
30,Transcriptional cascade regulating adipogenesis WP4211,0.013060302417467487,5.250223015165031,22.77640197629949,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG']",0.22855529230568103,0,0,5
31,Apoptosis Modulation and Signaling WP1772,0.013809045891715296,1.9730820995962315,8.449588742360968,"['JUN', 'ENDOG', 'CRADD', 'CDKN2A', 'BAD', 'BNIP3', 'FOS', 'NFKBIA', 'BCL2L11', 'CAPNS1', 'TOLLIP', 'PEA15', 'CYCS', 'PRKD1', 'FADD', 'BCL2L2', 'MAPK3', 'HSPA1A']",0.23386287397259772,0,0,18
32,Metabolic reprogramming in colon cancer WP4290,0.015913483125233423,2.3363658960974396,9.673929840149732,"['LDHA', 'PFKL', 'PKM', 'MDH2', 'PGAM1', 'FASN', 'PGK1', 'SUCLG2', 'PYCR2', 'PDHB', 'ENO1', 'GAPDH']",0.26108058252336086,0,0,12
33,Senescence and Autophagy in Cancer WP615,0.01686078750182648,1.8463986639251924,7.538411138022711,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'SPARC', 'CDKN1B', 'PCNA', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'HMGA1', 'BMI1', 'GABARAP', 'RSL1D1', 'MAP1LC3B', 'FKBP8', 'SLC39A1', 'HRAS', 'SLC39A3']",0.26823980116542123,0,0,20
34,"GPCRs, Other WP117",0.01750780173085153,2.4089147286821704,9.74432188850478,"['GPR162', 'ADGRV1', 'FSHR', 'ADGRF5', 'GPR88', 'GNRHR', 'OR2M4', 'ADRA1D', 'GPR83', 'CELSR2', 'RXFP1']",0.2703410561381486,0,0,11
35,Glycolysis in senescence WP5049,0.02082607530048273,4.37481415402914,16.937309363317095,"['LDHA', 'PKM', 'PGK1', 'ENO1', 'GAPDH']",0.3123911295072409,0,0,5
36,Complement system WP2806,0.021656719705696565,2.312361359570662,8.861984998067161,"['SELP', 'PRNP', 'FKBP2', 'RPS19', 'C1QBP', 'F12', 'CD59', 'TXN', 'CALR', 'KLKB1', 'C2']",0.31582716237474157,0,0,11
37,Gastrin signaling pathway WP4659,0.02504138361250652,1.7024190350297423,6.277202840510975,"['CHGA', 'EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'JAG1', 'CDKN1B', 'CDKN2A', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'ELK1', 'RHOB', 'NFKBIA', 'PRKCQ', 'PPARG', 'PRKD1', 'RAC1', 'HRAS', 'MEF2D', 'MAPK3']",0.34716627128024474,0,0,22
38,Spinal Cord Injury WP2431,0.02512822534980819,1.78475250064119,6.574606205331438,"['RTN4R', 'EGR1', 'CDKN1B', 'ARG1', 'XYLT1', 'MIF', 'TACR1', 'FOS', 'NTN1', 'RTN4', 'LTB4R', 'RHOB', 'SELP', 'FKBP1A', 'NR4A1', 'ACAN', 'NOX4', 'RAC1', 'MAPK3']",0.34716627128024474,0,0,19
39,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.02709467604045852,1.6244680023557911,5.861759623121333,"['YWHAE', 'CEBPB', 'YWHAB', 'HSP90B1', 'NEUROD1', 'YWHAQ', 'SCN5A', 'SCN3B', 'YWHAG', 'YWHAH', 'CHRNB2', 'EGR1', 'CPT1A', 'JUN', 'TSPYL1', 'SSTR1', 'TACR1', 'ADCYAP1', 'PRKAR1A', 'KCNQ1', 'BHLHE40', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2']",0.364736023621557,0,0,25
40,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.031076837729934408,3.7495221103606475,13.015687998277869,"['CD63', 'EGF', 'CD81', 'HSPB1', 'SOD1']",0.4078834952053891,0,0,5
41,Zinc homeostasis WP3529,0.04523870901508585,2.333978462607315,7.225535576438713,"['MT2A', 'SLC39A11', 'SLC30A1', 'SLC39A7', 'SLC30A10', 'SLC39A1', 'MT3', 'SLC39A3']",0.5691521242979298,0,0,8
42,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.04553216994383438,1.9927364135463574,6.156232681880277,"['NFKBIA', 'JUN', 'AHSA1', 'NFATC2', 'MAP3K8', 'PRKCQ', 'LCP2', 'FOS', 'CALM1', 'CALM2', 'MAPK3']",0.5691521242979298,0,0,11
43,Exercise-induced Circadian Regulation WP410,0.046904623388698156,1.9105958918039454,5.845733758584092,"['PER2', 'DNAJA1', 'DAZAP2', 'HSPA8', 'CEBPB', 'BTG1', 'RBPMS', 'GSTP1', 'SUMO3', 'GFRA1', 'TOB1', 'EIF4G2']",0.572672727420152,0,0,12
44,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.05557391539967962,2.2109494370137046,6.389735263222324,"['NFKBIA', 'NDUFA13', 'HSP90AA1', 'IL18', 'PRDM1', 'RAC1', 'NLRP1', 'AAMP']",0.6630978542007226,0,0,8
45,Differentiation of white and brown adipocyte WP2895,0.05966308440072331,2.915799385469323,8.21976035268422,"['CEBPA', 'CEBPB', 'EBF3', 'PPARG', 'ZNF423']",0.68587367226895,0,0,5
46,Pathways in clear cell renal cell carcinoma WP4018,0.060095597951184195,1.6245984508764777,4.56807628065455,"['TPI1', 'BHLHE41', 'PLOD2', 'ENO1', 'ENO2', 'ACACB', 'LDHB', 'TOX2', 'LDHA', 'PFKL', 'DEPTOR', 'PKM', 'FASN', 'PGK1', 'ALDOA', 'GAPDH', 'KCNJ2']",0.68587367226895,0,0,17
47,Development and heterogeneity of the ILC family WP3893,0.06157658911929032,3.4982909793431416,9.751393496213419,"['IL7', 'ID2', 'IL18', 'TOX']",0.6878236018644132,0,0,4
48,Alzheimer's disease WP2059,0.06853863688035801,1.6169361790159638,4.33396725808165,"['PSENEN', 'ATP5MD', 'BAD', 'ITPR2', 'LPL', 'GRIN2D', 'CDK5', 'CYCS', 'CALM3', 'FADD', 'CALM1', 'PLCB2', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.7097025935910936,0,0,16
49,7q11.23 copy number variation syndrome WP4932,0.06885936377767746,1.5237239934141595,4.077011620360542,"['PCNA', 'H2AFX', 'HMGA1', 'ATP5MC3', 'VPS37D', 'UBE2L6', 'NRG1', 'ACACB', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'GRIP1', 'ATP5F1B', 'CFL1', 'BCL7B', 'EIF4H', 'WNT2', 'GAPDH', 'VAMP2', 'MAPK3']",0.7097025935910936,0,0,20
50,Prolactin Signaling Pathway WP2037,0.06982371786233961,1.6420250896057347,4.370712054450637,"['JUN', 'RPS6', 'FOS', 'ELK1', 'VAV2', 'NFKBIA', 'TEC', 'RPS6KA2', 'RAC1', 'PPIB', 'CTSD', 'HRAS', 'PPIA', 'YWHAG', 'MAPK3']",0.7097025935910936,0,0,15
51,Monoamine GPCRs WP58,0.07029435212711783,2.422613531047266,6.432193543342333,"['CHRM1', 'CHRM5', 'HTR2B', 'ADRA1D', 'HTR5A', 'ADRA2C']",0.7097025935910936,0,0,6
52,Ovarian infertility WP34,0.07029435212711783,2.422613531047266,6.432193543342333,"['EGR1', 'CEBPB', 'CDKN1B', 'SMPD1', 'FSHR', 'ZP3']",0.7097025935910936,0,0,6
53,Aryl Hydrocarbon Receptor Pathway WP2873,0.07670094741408193,2.161580882352941,5.550596486785886,"['HSP90AA1', 'JUN', 'CDKN1B', 'JUND', 'AIP', 'AHRR', 'JUNB']",0.7321009678568307,0,0,7
54,Peptide GPCRs WP24,0.07670094741408193,2.161580882352941,5.550596486785886,"['FSHR', 'GNRHR', 'OPRL1', 'SSTR1', 'TACR1', 'SSTR3', 'HCRTR2']",0.7321009678568307,0,0,7
55,Photodynamic therapy-induced unfolded protein response WP3613,0.07670094741408193,2.161580882352941,5.550596486785886,"['XBP1', 'BCL2L11', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1']",0.7321009678568307,0,0,7
56,Kynurenine Pathway and links to Cellular Senescence WP5044,0.0780907699047286,2.6239964317573596,6.690884974901731,"['CDKN1A', 'TDO2', 'HAAO', 'KMO', 'ACMSD']",0.7321009678568307,0,0,5
57,Glucocorticoid Receptor Pathway WP2880,0.08302978573681637,1.7505963029218843,4.356456707847448,"['RGS2', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'B3GNT5', 'PLK2', 'ENC1', 'AMIGO2', 'BHLHE40']",0.7603066844224932,0,0,11
58,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.08486261728329203,2.998280364308006,7.39592292944776,"['RPH3AL', 'MYRIP', 'SYTL3', 'EXPH5']",0.7603066844224932,0,0,4
59,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.08689219250542779,3.9344919786096257,9.612306579634813,"['TPO', 'SPI1', 'ID2']",0.7603066844224932,0,0,3
60,NAD Biosynthesis II (from tryptophan) WP2485,0.08689219250542779,3.9344919786096257,9.612306579634813,"['TDO2', 'HAAO', 'KMO']",0.7603066844224932,0,0,3
61,Adipogenesis WP236,0.09090053410524558,1.459861298208851,3.5007319215979837,"['FZD1', 'GDF10', 'WWTR1', 'CEBPA', 'EGR2', 'CDKN1A', 'CEBPB', 'GADD45B', 'HMGA1', 'LPL', 'MIF', 'BSCL2', 'SFRP4', 'CYP26B1', 'DDIT3', 'NDN', 'SPOCK1', 'PPARG', 'PPARA', 'MEF2D']",0.7749300475067303,0,0,20
62,Proteasome Degradation WP183,0.0915155484674615,1.6257620326554973,3.887597595700925,"['PSMD10', 'H2AFZ', 'H2AFX', 'PSMB10', 'PSMD8', 'PSMB6', 'PSMC5', 'UBB', 'PSMC3', 'PSMB3', 'PSMD2', 'UBC', 'PSME1']",0.7749300475067303,0,0,13
63,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.09328788427672424,1.658495231367008,3.934058552787519,"['PPP2CA', 'FZD1', 'CDKN1A', 'JUN', 'CDKN1B', 'TMSB4X', 'NEFL', 'PFN4', 'PFN1', 'ELK1', 'PFN2', 'SOD1']",0.7773990356393687,0,0,12
64,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.09495699447654618,1.9089691014657517,4.494345476468256,"['PRKCG', 'PRKCH', 'FSHR', 'PRKCD', 'PRKCQ', 'HRAS', 'PLCB2', 'MAPK3']",0.7789440953154179,0,0,8
65,Circadian rhythm related genes WP3594,0.09876512394208316,1.3368959427536065,3.0949284564908894,"['AHCY', 'CHRM1', 'SUV39H1', 'CIPC', 'BHLHE41', 'OPRL1', 'DBP', 'UBC', 'RPS27A', 'SKP1', 'PRKCG', 'CHRNB2', 'KLF10', 'EGR1', 'CPT1A', 'JUN', 'EGR3', 'JUND', 'NR1D1', 'CARTPT', 'HCRTR2', 'NR2F6', 'PER2', 'ID2', 'BHLHE40', 'PPARG', 'GHRL', 'PPARA', 'UBA52', 'EZH2']",0.7977183087629793,0,0,30
66,White fat cell differentiation WP4149,0.10645418593756685,2.0992414100847836,4.702385915107378,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG', 'ZNF423']",0.8467946608670089,0,0,6
67,Nuclear receptors WP170,0.10981998463092474,1.9337171052631579,4.271412382398229,"['NR4A1', 'THRA', 'ESRRB', 'ROR1', 'PPARG', 'PPARA', 'NR2F6']",0.8503137682390706,0,0,7
68,Glycogen Synthesis and Degradation WP500,0.11051336069453953,1.7499255287459041,3.8544189628353775,"['PPP2CA', 'GYS1', 'GSK3A', 'PPP2R1A', 'PHKA1', 'CALM3', 'GYG2', 'CALM1', 'CALM2']",0.8503137682390706,0,0,9
69,Airway smooth muscle cell contraction WP4962,0.11175552382570642,2.623272403031654,5.748748315425895,"['RYR1', 'GDI1', 'CALM1', 'CALM2']",0.8503137682390706,0,0,4
70,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.11767634670807547,1.5753020134228188,3.3708584182802914,"['FZD1', 'SFRP4', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'CTBP2', 'CSNK2B', 'WNT7A', 'ROR1', 'WNT2', 'EZH2']",0.8616542419783774,0,0,12
71,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.12283541171810107,2.1862920011894142,4.584457419853152,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3G', 'EIF1']",0.8616542419783774,0,0,5
72,Blood Clotting Cascade WP272,0.12296728882700583,3.1473262032085563,6.596282403958712,"['F8A1', 'F12', 'KLKB1']",0.8616542419783774,0,0,3
73,miR-517 relationship with ARCN1 and USP1 WP3596,0.1230934631397682,5.244543429844098,10.986329098390357,"['CDKN1A', 'ID2']",0.8616542419783774,0,0,2
74,Nucleotide GPCRs WP80,0.1230934631397682,5.244543429844098,10.986329098390357,"['LPAR6', 'LTB4R']",0.8616542419783774,0,0,2
75,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.1230934631397682,5.244543429844098,10.986329098390357,"['ATP4A', 'CHRM1']",0.8616542419783774,0,0,2
76,Prostaglandin Synthesis and Regulation WP98,0.12880611562271385,1.836875,3.764577930381368,"['HSD11B1', 'HSD11B2', 'PTGER3', 'S100A6', 'MITF', 'PPARG', 'PTGES']",0.8897790881832207,0,0,7
77,Breast cancer pathway WP4262,0.13564699218926682,1.344029265743402,2.6849664758246212,"['SHC4', 'FZD1', 'JUN', 'CDKN1A', 'GADD45B', 'EGF', 'WNT7A', 'FOS', 'FGF1', 'DLL3', 'FGF17', 'SFRP4', 'FRAT1', 'FRAT2', 'HEY1', 'CSNK2B', 'WNT2', 'FGF23', 'HRAS', 'SKP1', 'FGF10', 'MAPK3']",0.9177017188616969,0,0,22
78,Modulators of TCR signaling and T cell activation WP5072,0.13946633596181648,1.5907397623982336,3.133649203159712,"['NFKBIA', 'FIBP', 'CDKN1B', 'NDUFB10', 'ELOB', 'MAP3K8', 'PRKCQ', 'LCP2', 'RNF7', 'MEF2D']",0.9177017188616969,0,0,10
79,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.14013042798057934,1.4838854073410923,2.9161043904767965,"['FZD1', 'JUN', 'CTBP2', 'WNT7A', 'SFRP4', 'FRAT1', 'FRAT2', 'SFRP2', 'HNRNPK', 'CSNK2B', 'ROR1', 'WNT2', 'EZH2']",0.9177017188616969,0,0,13
80,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.14093340874499208,1.301198516326837,2.5496565662614303,"['SHC4', 'RAB3A', 'ELK1', 'ACACB', 'PPP2CA', 'GRIP1', 'BCL2L11', 'CFL1', 'RAC1', 'HRAS', 'MAPK3', 'VAV3', 'EGR1', 'JUN', 'EGR2', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'EEF2', 'SYN1', 'VAV2', 'NFKBIA', 'MARCKS', 'CDK5', 'CDK5R1']",0.9177017188616969,0,0,26
81,PDGF Pathway WP2526,0.14333626846982694,1.6289636682998982,3.164362728348431,"['NFKBIA', 'JUN', 'ARFIP2', 'RAC1', 'FOS', 'ELK1', 'HRAS', 'MAPK3', 'VAV2']",0.9177017188616969,0,0,9
82,TGF-beta Receptor Signaling WP560,0.14333626846982694,1.6289636682998982,3.164362728348431,"['FKBP1A', 'JUN', 'EGF', 'FOS', 'ZNF423', 'HRAS', 'LTBP1', 'TGFBR1', 'MAPK3']",0.9177017188616969,0,0,9
83,TYROBP causal network in microglia WP3945,0.14879839061750746,2.0179441432786662,3.8445124621140585,"['RBM47', 'ADAP2', 'IL18', 'SAMSN1', 'TGFBR1']",0.9181730697908798,0,0,5
84,Hematopoietic Stem Cell Differentiation WP2849,0.15040549333717268,1.8519568469958265,3.5083847258351937,"['TPO', 'SPI1', 'NFATC2', 'FOSB', 'FOS', 'ABO']",0.9181730697908798,0,0,6
85,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.15040549333717268,1.8519568469958265,3.5083847258351937,"['YWHAQ', 'LPL', 'FOXO4', 'PRDM1', 'RAC1', 'NDRG1']",0.9181730697908798,0,0,6
86,Sleep regulation WP3591,0.15040549333717268,1.8519568469958265,3.5083847258351937,"['CHRNB2', 'AHCY', 'IL18', 'GHRL', 'FOS', 'HCRTR2']",0.9181730697908798,0,0,6
87,Melanoma WP4685,0.154131770745826,1.4521895655155337,2.7155180852625316,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'MITF', 'FOS', 'ELK1', 'CALM3', 'RAC1', 'CALM1', 'HRAS', 'CALM2', 'MAPK3']",0.9206100609562444,0,0,13
88,Corticotropin-releasing hormone signaling pathway WP2355,0.15526121212221386,1.4064900153609832,2.619793480747525,"['GNAZ', 'HSP90AA1', 'JUND', 'PRKCD', 'IL18', 'FOS', 'ELK1', 'NFKBIA', 'NR4A1', 'GNB2', 'GNAS', 'FOSB', 'PRKCQ', 'JUNB', 'MAPK3']",0.9206100609562444,0,0,15
89,Synaptic Vesicle Pathway WP2267,0.15606532461924905,1.543821820189855,2.8676190991128796,"['RAB3A', 'CLTCL1', 'AP2S1', 'SLC17A7', 'PARK7', 'SYN3', 'SLC25A4', 'AP2M1', 'SYN1', 'VAMP2']",0.9206100609562444,0,0,10
90,Oncostatin M Signaling Pathway WP2374,0.16038334201673163,1.4650226314968005,2.6812674870036113,"['NFKBIA', 'EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'JUND', 'PRKCD', 'RPS6', 'FOS', 'JUNB', 'HRAS', 'MAPK3']",0.9322511687108422,0,0,12
91,Genes targeted by miRNAs in adipocytes WP1992,0.16336591908837617,2.622549019607843,4.7514364711979225,"['TMSB4X', 'KCNQ1', 'KCNJ2']",0.9322511687108422,0,0,3
92,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.16336591908837617,2.622549019607843,4.7514364711979225,"['JUN', 'PRKCQ', 'MAPK3']",0.9322511687108422,0,0,3
93,MAPK pathway in congenital thyroid cancer WP4928,0.17475615701535308,2.0982612572447614,3.6601306972572214,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.9470224964151503,0,0,4
94,Cell migration and invasion through p75NTR WP4561,0.1749736802900373,1.7489216123754276,3.048579742017912,"['EFNA1', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'RAC1']",0.9470224964151503,0,0,6
95,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.1749736802900373,1.7489216123754276,3.048579742017912,"['EGR2', 'RAB3A', 'HSPB1', 'NEFL', 'RABAC1', 'NDRG1']",0.9470224964151503,0,0,6
96,Oxidative Stress WP408,0.1749736802900373,1.7489216123754276,3.048579742017912,"['GPX3', 'NOX4', 'FOS', 'JUNB', 'TXN2', 'SOD1']",0.9470224964151503,0,0,6
97,Pre-implantation embryo WP3527,0.1749736802900373,1.7489216123754276,3.048579742017912,"['EGR1', 'DDIT3', 'AQP9', 'HMGA1', 'FOSB', 'HNRNPAB']",0.9470224964151503,0,0,6
98,Tryptophan metabolism WP465,0.20103925225079503,1.656732191925597,2.657821076777627,"['TDO2', 'HAAO', 'ALDH1A1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.9999913070358183,0,0,6
99,Complement and Coagulation Cascades WP558,0.2066636507242937,1.7485875706214689,2.756932770534008,"['SERPIND1', 'F12', 'CLU', 'KLKB1', 'C2']",0.9999913070358183,0,0,5
100,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.2066636507242937,1.7485875706214689,2.756932770534008,"['NFKBIA', 'GSK3A', 'NFATC2', 'CALM1', 'CALM2']",0.9999913070358183,0,0,5
101,Dopamine metabolism WP2436,0.2069899263300844,2.2477081741787623,3.540331771117326,"['PPP2CA', 'TYR', 'SOD1']",0.9999913070358183,0,0,3
102,Neuroinflammation WP4919,0.2069899263300844,2.2477081741787623,3.540331771117326,"['NFKBIA', 'JUN', 'FOS']",0.9999913070358183,0,0,3
103,Wnt signaling pathway and pluripotency WP399,0.21256797255397053,1.3122759856630823,2.032050795848619,"['PRKCG', 'FZD1', 'JUN', 'PRKCH', 'CTBP2', 'PRKCD', 'ESRRB', 'WNT7A', 'ZBTB33', 'PPP2CA', 'FRAT1', 'PPP2R1A', 'PRKCQ', 'PRKD1', 'WNT2']",0.9999913070358183,0,0,15
104,T-cell receptor (TCR) signaling pathway WP69,0.21683440526080305,1.3378359401056752,2.0450445489422764,"['VAV3', 'IL15RA', 'JUN', 'PRKCD', 'NFATC2', 'FOS', 'NFKBIA', 'MAP3K8', 'PRKCQ', 'LCP2', 'HRAS', 'SKAP1', 'MAPK3']",0.9999913070358183,0,0,13
105,G Protein Signaling Pathways WP35,0.2176525954136929,1.2921146088335689,1.9702875334171235,"['PRKCG', 'GNAZ', 'PRKCH', 'PRKCD', 'AKAP5', 'GNG13', 'GNG10', 'GNG3', 'PRKAR1A', 'GNB2', 'GNAS', 'PRKCQ', 'PRKD1', 'CALM1', 'HRAS', 'CALM2']",0.9999913070358183,0,0,16
106,CAMKK2  Pathway WP4874,0.2188139170642575,1.5302083333333334,2.325202983820555,"['FIS1', 'WFS1', 'NFATC2', 'RAC1', 'CALM1', 'CALM2', 'MAPK3']",0.9999913070358183,0,0,7
107,Oxidative Damage WP3941,0.2188139170642575,1.5302083333333334,2.325202983820555,"['CDKN1A', 'PCNA', 'CDKN1B', 'BAD', 'CYCS', 'NFKBIE', 'C2']",0.9999913070358183,0,0,7
108,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.2214522923441356,1.4310260784791615,2.157340641578083,"['FKBP1A', 'JUN', 'EGF', 'FOS', 'ZNF423', 'HRAS', 'LTBP1', 'TGFBR1', 'MAPK3']",0.9999913070358183,0,0,9
109,Wnt signaling WP428,0.2282058688829279,1.2906530936012692,1.906949140060111,"['PRKCG', 'FZD1', 'JUN', 'CTBP2', 'NFATC2', 'WNT7A', 'SFRP4', 'FRAT1', 'FRAT2', 'SFRP2', 'CSNK2B', 'ROR1', 'RAC1', 'WNT2', 'PLCB2']",0.9999913070358183,0,0,15
110,Development of ureteric collection system WP5053,0.22840503383277924,1.5737617135207496,2.3238712531243038,"['GRIP1', 'FRAS1', 'GREB1L', 'ITGA8', 'GFRA1', 'FAT4']",0.9999913070358183,0,0,6
111,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.23118037807968614,1.3808437051502247,2.0223243359396346,"['PRKCG', 'IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'PRKCQ', 'ISG15', 'HRAS', 'PLCB2', 'MAPK3']",0.9999913070358183,0,0,10
112,Common Pathways Underlying Drug Addiction WP2636,0.23241974220065315,1.4473210022947436,2.111945726089266,"['PRKCG', 'PPP1R1A', 'GNAS', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9999913070358183,0,0,8
113,16p11.2 proximal deletion syndrome WP4949,0.23401089349299167,1.311996418979409,1.9055273450207928,"['PCNA', 'IGFBP3', 'SEZ6L2', 'CORO1A', 'PPP2CA', 'PPP2R1A', 'TCP1', 'PPARG', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3', 'MAPK3']",0.9999913070358183,0,0,13
114,Cardiac Progenitor Differentiation WP2406,0.2379791096396887,1.6391614629794826,2.353134928819991,"['MESP1', 'ACTC1', 'NRG1', 'SCN5A', 'THY1']",0.9999913070358183,0,0,5
115,Differentiation Pathway WP2848,0.2379791096396887,1.6391614629794826,2.353134928819991,"['TPO', 'EGF', 'FGF1', 'WNT2', 'FGF10']",0.9999913070358183,0,0,5
116,G13 Signaling Pathway WP524,0.24419660280033195,1.468875,2.070792990222244,"['CFL2', 'CFL1', 'ARHGDIG', 'RAC1', 'PFN1', 'CALM1', 'CALM2']",0.9999913070358183,0,0,7
117,Proteoglycan biosynthesis WP4784,0.24681042921855104,1.7482538267201664,2.4460426459420193,"['CANT1', 'XYLT1', 'B3GALT6', 'PAPSS2']",0.9999913070358183,0,0,4
118,ACE Inhibitor Pathway WP554,0.24776687842725803,2.621826280623608,3.658147639906327,"['MAS1', 'ATP6AP2']",0.9999913070358183,0,0,2
119,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.24776687842725803,2.621826280623608,3.658147639906327,"['HSD11B1', 'HSD11B2']",0.9999913070358183,0,0,2
120,LDLRAD4 and what we know about it WP4904,0.24776687842725803,2.621826280623608,3.658147639906327,"['PMEPA1', 'TGFBR1']",0.9999913070358183,0,0,2
121,Nephrogenesis WP5052,0.24776687842725803,2.621826280623608,3.658147639906327,"['JAG1', 'GREB1L']",0.9999913070358183,0,0,2
122,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.25278766916507384,1.9665775401069518,2.7044480427149784,"['CDKN1A', 'FGF23', 'PHEX']",0.9999913070358183,0,0,3
123,Hypertrophy Model WP516,0.25278766916507384,1.9665775401069518,2.7044480427149784,"['JUND', 'WDR1', 'IL18']",0.9999913070358183,0,0,3
124,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.25278766916507384,1.9665775401069518,2.7044480427149784,"['PTTG1', 'ANAPC11', 'MAD2L1']",0.9999913070358183,0,0,3
125,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.2568618670803371,1.4986931854401735,2.0370489868085464,"['CREB3', 'ITPR2', 'CALM3', 'CALM1', 'PLCB2', 'CALM2']",0.9999913070358183,0,0,6
126,TNF-alpha signaling pathway WP231,0.26083699632636836,1.2494666325311488,1.6791077313940999,"['HSP90AA1', 'JUN', 'BAD', 'TXN', 'PPP2CA', 'NFKBIA', 'PSMD2', 'RFK', 'MAP3K8', 'RAC1', 'FADD', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9999913070358183,0,0,15
127,p38 MAPK Signaling Pathway WP400,0.2704351817198777,1.4122596153846154,1.8468441456792852,"['DDIT3', 'HSPB1', 'RAC1', 'ELK1', 'HRAS', 'MEF2D', 'TGFBR1']",0.9999913070358183,0,0,7
128,7-oxo-C and 7beta-HC pathways WP5064,0.270468865281601,1.5426090150600829,2.0171129070575895,"['HSD11B1', 'HSD11B2', 'DBP', 'EPHX2', 'ACOT6']",0.9999913070358183,0,0,5
129,Physiological and pathological hypertrophy of the heart WP1528,0.270468865281601,1.5426090150600829,2.0171129070575895,"['JUN', 'RAC1', 'FOS', 'CALM1', 'CALM2']",0.9999913070358183,0,0,5
130,Triacylglyceride synthesis WP325,0.2849565860574488,1.6136355842107069,2.0257878677611676,"['DGAT2', 'MOGAT1', 'LPL', 'AGPAT1']",0.9999913070358183,0,0,4
131,Prion disease pathway WP3995,0.2861941851906017,1.4304490690032858,1.7896129863567831,"['PRNP', 'SPI1', 'HSPA5', 'ELK1', 'HSP90B1', 'MAPK3']",0.9999913070358183,0,0,6
132,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.28853767290316623,1.311438784629133,1.6300261096715225,"['VAV3', 'BEX3', 'CDKN1A', 'CDKN1B', 'JUND', 'HSPA5', 'HSPB1', 'NRG1', 'RNF7']",0.9999913070358183,0,0,9
133,COVID-19 adverse outcome pathway WP4891,0.29480690166799,5.242653606411398,6.4035590747122475,['IL7'],0.9999913070358183,0,0,1
134,Gastric acid production WP2596,0.29480690166799,5.242653606411398,6.4035590747122475,['CCK'],0.9999913070358183,0,0,1
135,MED and Pseudoachondroplasia genes WP4789,0.29480690166799,5.242653606411398,6.4035590747122475,['MATN1'],0.9999913070358183,0,0,1
136,Nanomaterial-induced inflammasome activation WP3890,0.29480690166799,5.242653606411398,6.4035590747122475,['CTSB'],0.9999913070358183,0,0,1
137,SCFA and skeletal muscle substrate metabolism WP4030,0.29480690166799,5.242653606411398,6.4035590747122475,['PYY'],0.9999913070358183,0,0,1
138,Thyroxine (Thyroid Hormone) Production WP1981,0.29480690166799,5.242653606411398,6.4035590747122475,['TPO'],0.9999913070358183,0,0,1
139,Ferroptosis WP4313,0.29736979028078775,1.3598379629629629,1.6491826930789728,"['PRNP', 'MAP1LC3B', 'GPX4', 'FTH1', 'PCBP1', 'SLC7A11', 'FTL']",0.9999913070358183,0,0,7
140,NO/cGMP/PKG mediated Neuroprotection WP4008,0.29736979028078775,1.3598379629629629,1.6491826930789728,"['NFKBIA', 'BAD', 'NEFL', 'CYCS', 'CALM1', 'CALM2', 'GRIN2D']",0.9999913070358183,0,0,7
141,Cell Differentiation - Index expanded WP2023,0.29979838034428724,1.7479203802733214,2.105623713914093,"['ID2', 'MEF2D', 'EZH2']",0.9999913070358183,0,0,3
142,Major receptors targeted by epinephrine and norepinephrine WP4589,0.29979838034428724,1.7479203802733214,2.105623713914093,"['ADCY10', 'ADRA1D', 'ADRA2C']",0.9999913070358183,0,0,3
143,miRNAs involved in DNA damage response WP1545,0.29979838034428724,1.7479203802733214,2.105623713914093,"['CDKN1A', 'CDKN1B', 'H2AFX']",0.9999913070358183,0,0,3
144,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.29979838034428724,1.7479203802733214,2.105623713914093,"['FZD1', 'SFRP4', 'DKK3']",0.9999913070358183,0,0,3
145,16p11.2 distal deletion syndrome WP4950,0.303819798183731,1.4567846169095053,1.7354974109362775,"['PLN', 'CD81', 'NFATC2', 'TUFM', 'VAV2']",0.9999913070358183,0,0,5
146,Prader-Willi and Angelman Syndrome WP3998,0.3056682482970709,1.3112996873604288,1.5542244074071396,"['OCA2', 'CDKN2C', 'CDKN2A', 'NDN', 'GHRL', 'TYR', 'GABRG3', 'GABRD']",0.9999913070358183,0,0,8
147,Bile acids synthesis and enterohepatic circulation  WP4389,0.3121167468037917,2.09728285077951,2.4420299539481722,"['ABCG8', 'MAPK3']",0.9999913070358183,0,0,2
148,Dual hijack model of Vif in HIV infection WP3300,0.3121167468037917,2.09728285077951,2.4420299539481722,"['UBB', 'ELOB']",0.9999913070358183,0,0,2
149,Liver X receptor pathway WP2874,0.3121167468037917,2.09728285077951,2.4420299539481722,"['ABCG8', 'FASN']",0.9999913070358183,0,0,2
150,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3121167468037917,2.09728285077951,2.4420299539481722,"['LPL', 'LDLRAP1']",0.9999913070358183,0,0,2
151,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3121167468037917,2.09728285077951,2.4420299539481722,"['AHCY', 'MAT2B']",0.9999913070358183,0,0,2
152,Osteoblast Signaling WP322,0.3121167468037917,2.09728285077951,2.4420299539481722,"['BGLAP', 'FGF23']",0.9999913070358183,0,0,2
153,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.3121167468037917,2.09728285077951,2.4420299539481722,"['ELK1', 'MEF2D']",0.9999913070358183,0,0,2
154,Sulfation Biotransformation Reaction WP692,0.3121167468037917,2.09728285077951,2.4420299539481722,"['SULT4A1', 'PAPSS2']",0.9999913070358183,0,0,2
155,Vitamin A and carotenoid metabolism WP716,0.3161850778037801,1.3681392235609102,1.5753131909488416,"['ABCG8', 'CYP26B1', 'RBP4', 'RBP2', 'ALDH1A1', 'LPL']",0.9999913070358183,0,0,6
156,Globo Sphingolipid Metabolism WP1424,0.323858921835381,1.4982485192025985,1.6891962244053556,"['FUT2', 'ST6GALNAC3', 'FUT1', 'ABO']",0.9999913070358183,0,0,4
157,Heart Development WP1591,0.323858921835381,1.4982485192025985,1.6891962244053556,"['HEY1', 'BHLHE40', 'NFATC2', 'FGF10']",0.9999913070358183,0,0,4
158,Methionine De Novo and Salvage Pathway WP3580,0.323858921835381,1.4982485192025985,1.6891962244053556,"['AHCY', 'AMD1', 'TXN', 'MAT2B']",0.9999913070358183,0,0,4
159,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.323858921835381,1.4982485192025985,1.6891962244053556,"['JUN', 'SRXN1', 'GSTP1', 'FOS']",0.9999913070358183,0,0,4
160,"Relationship between inflammation, COX-2 and EGFR WP4483",0.323858921835381,1.4982485192025985,1.6891962244053556,"['PTGES2', 'PTGER3', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,4
161,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.323858921835381,1.4982485192025985,1.6891962244053556,"['HTR2B', 'ELK1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,4
162,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.323858921835381,1.4982485192025985,1.6891962244053556,"['EGR1', 'GNAS', 'ELK1', 'MAPK3']",0.9999913070358183,0,0,4
163,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.323858921835381,1.4982485192025985,1.6891962244053556,"['MDH2', 'IDH3G', 'IDH3B', 'SUCLG2']",0.9999913070358183,0,0,4
164,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.32411257899120355,1.2105317501290656,1.3638629765166195,"['CDKN1A', 'JUN', 'BCL2L11', 'GADD45B', 'DCC', 'BAD', 'CYCS', 'RAC1', 'FOS', 'NTN1', 'TGFBR1', 'MAPK3']",0.9999913070358183,0,0,12
165,IL-3 signaling pathway WP286,0.3248389775618675,1.3111607142857142,1.4743027686845163,"['JUN', 'YWHAQ', 'YWHAB', 'BAD', 'FOS', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,7
166,IL-6 signaling pathway WP364,0.3248389775618675,1.3111607142857142,1.4743027686845163,"['BAD', 'PRKCD', 'PRDM1', 'RAC1', 'JUNB', 'MAPK3', 'NR2F6']",0.9999913070358183,0,0,7
167,Cytosolic DNA-sensing pathway WP4655,0.3311549328722914,1.2714550597534073,1.405172638070864,"['NFKBIA', 'IL18', 'ISG15', 'POLR3H', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999913070358183,0,0,8
168,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.3311549328722914,1.2714550597534073,1.405172638070864,"['CDKN1A', 'HSP90AA1', 'JUN', 'BCL2L11', 'CDKN2A', 'FOS', 'ELK1', 'JUNB']",0.9999913070358183,0,0,8
169,PI3K-Akt signaling pathway WP4172,0.3447048412620103,1.0920384938157348,1.1630939011696901,"['CDKN1A', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'FLT3', 'LAMA4', 'LAMA3', 'FGF1', 'HSP90B1', 'PPP2CA', 'GYS1', 'GNG10', 'GNG3', 'BCL2L11', 'PPP2R1A', 'PDGFD', 'RAC1', 'HRAS', 'FGF23', 'EIF4B', 'MAPK3', 'HSP90AA1', 'EGF', 'BAD', 'RPS6', 'GNG13', 'EFNA1', 'FGF17', 'CREB3', 'EFNA3', 'LPAR6', 'IL7', 'GNB2', 'DDIT4', 'ITGA8', 'FGF10']",0.9999913070358183,0,0,36
170,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.34662075952602156,1.3110218652387327,1.3890591421876548,"['LDHA', 'PFKL', 'PKM', 'IGFBP3', 'BNIP3', 'PGK1']",0.9999913070358183,0,0,6
171,BMP Signaling Pathway in Eyelid Development WP3927,0.347176160675852,1.5729946524064171,1.66410715905438,"['JUN', 'MAPK3', 'FGF10']",0.9999913070358183,0,0,3
172,Nicotine Activity on Dopaminergic Neurons WP1602,0.347176160675852,1.5729946524064171,1.66410715905438,"['CHRNB2', 'CDK5', 'PPP1R1B']",0.9999913070358183,0,0,3
173,Tryptophan catabolism leading to NAD+ production WP4210,0.347176160675852,1.5729946524064171,1.66410715905438,"['TDO2', 'HAAO', 'KMO']",0.9999913070358183,0,0,3
174,Osteoblast differentiation WP4787,0.3485617349950303,1.157099936748893,1.219513814280119,"['PRKCG', 'FZD1', 'PRKCH', 'JAG1', 'PRKCD', 'WNT7A', 'FGF1', 'DLL3', 'HEY1', 'PRKCQ', 'PPARG', 'PRKD1', 'WNT2', 'FGF10', 'MAPK3']",0.9999913070358183,0,0,15
175,Metapathway biotransformation Phase I and II WP702,0.34933180051436674,1.1497270712193683,1.2092060059823821,"['CHST9', 'GPX4', 'GPX3', 'GSTO1', 'EPHX2', 'GSTP1', 'CYP3A43', 'GLYAT', 'CYP2C18', 'CYP3A7', 'CYP39A1', 'CYP26B1', 'CHST1', 'NAT8L', 'SULT4A1', 'CHST2']",0.9999913070358183,0,0,16
176,Cardiac Hypertrophic Response WP2795,0.36006056078308785,1.2102495359868013,1.2362493718897185,"['EGF', 'NFATC2', 'NRG1', 'RAC1', 'PRKD1', 'CALM1', 'CALM2', 'TGFBR1', 'MAPK3']",0.9999913070358183,0,0,9
177,Canonical and non-canonical Notch signaling WP3845,0.3630651445455406,1.3982463961955713,1.4166654949388233,"['JAG1', 'HEY1', 'CNTN6', 'DLL3']",0.9999913070358183,0,0,4
178,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3630651445455406,1.3982463961955713,1.4166654949388233,"['LDHA', 'RPS6', 'PDHB', 'ACACB']",0.9999913070358183,0,0,4
179,IL-7 signaling pathway WP205,0.3630651445455406,1.3982463961955713,1.4166654949388233,"['CDKN1B', 'BAD', 'IL7', 'MAPK3']",0.9999913070358183,0,0,4
180,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.37516655051816006,1.7475872308834446,1.7133086863930567,"['JAG1', 'WNT2']",0.9999913070358183,0,0,2
181,Canonical NF-KB pathway WP4562,0.37516655051816006,1.7475872308834446,1.7133086863930567,"['NFKBIA', 'NFKBIE']",0.9999913070358183,0,0,2
182,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.37516655051816006,1.7475872308834446,1.7133086863930567,"['CEBPB', 'ALDH1A1']",0.9999913070358183,0,0,2
183,IL1 and megakaryocytes in obesity WP2865,0.37516655051816006,1.7475872308834446,1.7133086863930567,"['IL18', 'TIMP2']",0.9999913070358183,0,0,2
184,Leptin and adiponectin WP3934,0.37516655051816006,1.7475872308834446,1.7133086863930567,"['CPT1A', 'LEPR']",0.9999913070358183,0,0,2
185,IL-5 signaling pathway WP127,0.3772943941997717,1.2584738955823294,1.226671643331766,"['GSK3A', 'JUN', 'RPS6', 'FOS', 'ELK1', 'MAPK3']",0.9999913070358183,0,0,6
186,Copper homeostasis WP3286,0.38298167440945974,1.1985963121291392,1.1503745512345542,"['PRNP', 'MT2A', 'JUN', 'SCO2', 'COX17', 'MT3', 'ATOX1', 'SOD1']",0.9999913070358183,0,0,8
187,Androgen receptor signaling pathway WP138,0.38562509469223427,1.1295876537255847,1.076372371314561,"['CDKN1A', 'JUN', 'DSTN', 'RNF6', 'PARK7', 'ETV5', 'RHOB', 'PRDX1', 'BAG1', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'RAN']",0.9999913070358183,0,0,14
188,B Cell Receptor Signaling Pathway WP23,0.3858620260692241,1.1362876753207998,1.0820588219305092,"['JUN', 'GSK3A', 'CD81', 'PRKCD', 'NFATC2', 'ELK1', 'ILF2', 'VAV2', 'NFKBIA', 'TEC', 'RAC1', 'HRAS', 'MEF2D']",0.9999913070358183,0,0,13
189,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.3941997845402171,1.4298736023334955,1.3310656628359823,"['GSK3A', 'BCL2L14', 'BCL2L2']",0.9999913070358183,0,0,3
190,Endothelin Pathways WP2197,0.4060636136333463,1.2483539356866744,1.1250733018158543,"['ADCY10', 'GNAS', 'CALM1', 'CALM2', 'GNG13']",0.9999913070358183,0,0,5
191,Oxidation by Cytochrome P450 WP43,0.4060636136333463,1.2483539356866744,1.1250733018158543,"['CYP39A1', 'CYP26B1', 'CYP3A43', 'CYP2C18', 'CYP3A7']",0.9999913070358183,0,0,5
192,let-7 inhibition of ES cell reprogramming WP3299,0.40782071696110467,2.6211041852181656,2.3509407395735047,['EGR1'],0.9999913070358183,0,0,1
193,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.40782071696110467,2.6211041852181656,2.3509407395735047,['MAS1'],0.9999913070358183,0,0,1
194,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.4080092600566945,1.2099680774379569,1.0846945269553256,"['NFKBIA', 'JUN', 'TNFSF12', 'FADD', 'RAC1', 'MAPK3']",0.9999913070358183,0,0,6
195,Vitamin D-sensitive calcium signaling in depression WP4698,0.4080092600566945,1.2099680774379569,1.0846945269553256,"['CHRM1', 'CALB1', 'GPX4', 'KCNQ3', 'ITPR2', 'GRIN2D']",0.9999913070358183,0,0,6
196,Aryl Hydrocarbon Receptor Netpath WP2586,0.40887216014505073,1.1839717741935485,1.0588883987710753,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'LPL', 'AHRR', 'HRAS']",0.9999913070358183,0,0,7
197,MAPK Signaling Pathway WP382,0.4194400020889692,1.055357260889682,0.9169310996415838,"['HSPB1', 'FGF1', 'ELK1', 'STMN1', 'FLNB', 'MAP3K8', 'RAC1', 'HRAS', 'FGF23', 'MAPK3', 'PRKCG', 'DUSP4', 'HSPA8', 'JUN', 'DUSP2', 'JUND', 'DUSP3', 'HSPA1L', 'DUSP1', 'EGF', 'PRKCD', 'CACNA2D3', 'FOS', 'MAPK8IP2', 'DUSP6', 'TGFBR1', 'DUSP7', 'FGF17', 'NR4A1', 'DDIT3', 'HSPA1B', 'HSPA1A', 'FGF10']",0.9999913070358183,0,0,33
198,RANKL/RANK signaling pathway WP2018,0.43514059506877395,1.1336141858696571,0.9432645989564838,"['NFKBIA', 'JUN', 'SPI1', 'MITF', 'RAC1', 'FOS', 'PAPSS2', 'MAPK3']",0.9999913070358183,0,0,8
199,Estrogen Receptor Pathway WP2881,0.43568099383063014,1.497804645243398,1.244443453980954,"['JUN', 'PPARA']",0.9999913070358183,0,0,2
200,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.43568099383063014,1.497804645243398,1.244443453980954,"['PRKCQ', 'MAFK']",0.9999913070358183,0,0,2
201,Glutathione metabolism WP100,0.43568099383063014,1.497804645243398,1.244443453980954,"['GPX4', 'GPX3']",0.9999913070358183,0,0,2
202,Matrix Metalloproteinases WP129,0.43568099383063014,1.497804645243398,1.244443453980954,"['BSG', 'TIMP2']",0.9999913070358183,0,0,2
203,Purine metabolism WP4792,0.43568099383063014,1.497804645243398,1.244443453980954,"['PRPS1', 'APRT']",0.9999913070358183,0,0,2
204,Serotonin and anxiety-related events WP3944,0.43568099383063014,1.497804645243398,1.244443453980954,"['FOS', 'GRIN2D']",0.9999913070358183,0,0,2
205,Thiamine metabolic pathways WP4297,0.43568099383063014,1.497804645243398,1.244443453980954,"['BCKDK', 'SLC19A3']",0.9999913070358183,0,0,2
206,Trans-sulfuration pathway WP2333,0.43568099383063014,1.497804645243398,1.244443453980954,"['AHCY', 'MAT2B']",0.9999913070358183,0,0,2
207,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.43858126688008664,1.1650552828598344,0.9602503953652526,"['JUN', 'RPS6KA2', 'DDIT3', 'FOS', 'JUNB', 'MAPK3']",0.9999913070358183,0,0,6
208,Parkinson's disease pathway WP2371,0.43858126688008664,1.1650552828598344,0.9602503953652526,"['PINK1', 'UBB', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.9999913070358183,0,0,6
209,Alpha 6 Beta 4 signaling pathway WP244,0.4399730894103249,1.191509204444084,0.9782787599059372,"['LAMA3', 'PRKCD', 'RAC1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,5
210,ERK Pathway in Huntington's Disease WP3853,0.4402729103211553,1.3106060606060606,1.075169434814796,"['EGF', 'ELK1', 'HRAS']",0.9999913070358183,0,0,3
211,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.4402729103211553,1.3106060606060606,1.075169434814796,"['JUN', 'PRKCQ', 'MAPK3']",0.9999913070358183,0,0,3
212,Type II interferon signaling (IFNG) WP619,0.4407975854765106,1.2335370171251738,1.0104759000111534,"['SPI1', 'PRKCD', 'TAP1', 'ISG15']",0.9999913070358183,0,0,4
213,Cell cycle WP179,0.4565301538498923,1.0618613438941498,0.8326060390222573,"['YWHAE', 'CDKN2D', 'CDKN1A', 'CDKN1B', 'PCNA', 'CDKN2C', 'GADD45B', 'YWHAB', 'CDKN2A', 'ANAPC11', 'PTTG1', 'YWHAQ', 'TFDP2', 'YWHAG', 'SKP1', 'YWHAH']",0.9999913070358183,0,0,16
214,3q29 copy number variation syndrome WP4906,0.45764324387274924,1.0972940956418729,0.8577167644472241,"['JUN', 'NCBP2', 'DYNLT3', 'MAD2L1BP', 'FBXO45', 'SLC51A', 'DYNLRB1', 'DYNLL1', 'DYNLL2']",0.9999913070358183,0,0,9
215,PDGFR-beta pathway WP3972,0.4734032720913749,1.139607493309545,0.8522072243211608,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,5
216,Estrogen signaling pathway WP712,0.47864839571086665,1.1649081091791746,0.8582914683790882,"['JUN', 'GNAS', 'FOS', 'ELK1']",0.9999913070358183,0,0,4
217,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.47864839571086665,1.1649081091791746,0.8582914683790882,"['PPP2CA', 'CDKN1A', 'THRA', 'MAPK3']",0.9999913070358183,0,0,4
218,Unfolded protein response WP4925,0.47864839571086665,1.1649081091791746,0.8582914683790882,"['XBP1', 'BCL2L11', 'HSPA5', 'DDIT3']",0.9999913070358183,0,0,4
219,Hepatitis B infection WP4666,0.48118198842580573,1.0375523638539796,0.7589796455166516,"['PRKCG', 'JUN', 'EGR2', 'CDKN1A', 'EGR3', 'PCNA', 'ATP6AP1', 'YWHAB', 'BAD', 'NFATC2', 'FOS', 'ELK1', 'TGFBR1', 'CREB3', 'YWHAQ', 'CYCS', 'FADD', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,19
220,Microglia Pathogen Phagocytosis Pathway WP3937,0.4849180776869363,1.2096873714520773,0.8755418574745507,"['VAV3', 'RAC1', 'VAV2']",0.9999913070358183,0,0,3
221,Pregnane X receptor pathway WP2876,0.4849180776869363,1.2096873714520773,0.8755418574745507,"['HSP90AA1', 'PSMC5', 'CYP3A7']",0.9999913070358183,0,0,3
222,Transcription factor regulation in adipogenesis WP3599,0.4849180776869363,1.2096873714520773,0.8755418574745507,"['CEBPA', 'CEBPB', 'PPARG']",0.9999913070358183,0,0,3
223,Kit receptor signaling pathway WP304,0.4867354674595445,1.0752968930726858,0.7742508515588377,"['TEC', 'BAD', 'RPS6', 'MITF', 'FOS', 'JUNB', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,8
224,Dopaminergic Neurogenesis WP2855,0.4928537325509647,1.310467706013363,0.9272120391619213,"['NEUROD1', 'ALDH1A1']",0.9999913070358183,0,0,2
225,ID signaling pathway WP53,0.4928537325509647,1.310467706013363,0.9272120391619213,"['ID2', 'ELK1']",0.9999913070358183,0,0,2
226,Nanoparticle triggered regulated necrosis WP2513,0.4928537325509647,1.310467706013363,0.9272120391619213,"['FADD', 'FTL']",0.9999913070358183,0,0,2
227,Ebola Virus Pathway on Host WP4217,0.4964078443972835,1.0345925297113752,0.7245845581741985,"['VPS18', 'VPS4A', 'MERTK', 'ACTB', 'ACTG1', 'RHOB', 'VAV2', 'C1QBP', 'CLTCL1', 'TYRO3', 'FLNB', 'RAC1', 'CTSB', 'HLA-DQB1', 'MAPK3']",0.9999913070358183,0,0,15
228,Fas ligand pathway and stress induction of heat shock proteins WP314,0.49863433607056407,1.0845219960300974,0.7546996016754618,"['JUN', 'HSPB1', 'CYCS', 'FADD', 'ACTB', 'ACTG1']",0.9999913070358183,0,0,6
229,Hepatitis C and Hepatocellular Carcinoma WP3646,0.49863433607056407,1.0845219960300974,0.7546996016754618,"['CDKN1A', 'JUN', 'RAC1', 'TGFBR1', 'VAV2', 'MAPK3']",0.9999913070358183,0,0,6
230,Cells and molecules involved in local acute inflammatory response  WP4493,0.502729747375486,1.7472543781537548,1.2015912648483227,['SELP'],0.9999913070358183,0,0,1
231,Composition of Lipid Particles WP3601,0.502729747375486,1.7472543781537548,1.2015912648483227,['LPL'],0.9999913070358183,0,0,1
232,Fatty Acid Omega Oxidation WP206,0.502729747375486,1.7472543781537548,1.2015912648483227,['ALDH1A1'],0.9999913070358183,0,0,1
233,Irinotecan pathway WP229,0.502729747375486,1.7472543781537548,1.2015912648483227,['ABCC1'],0.9999913070358183,0,0,1
234,Platelet-mediated interactions with vascular and circulating cells WP4462,0.502729747375486,1.7472543781537548,1.2015912648483227,['SELP'],0.9999913070358183,0,0,1
235,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.502729747375486,1.7472543781537548,1.2015912648483227,['RAC1'],0.9999913070358183,0,0,1
236,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.502729747375486,1.7472543781537548,1.2015912648483227,['DLL3'],0.9999913070358183,0,0,1
237,Vitamin B6-dependent and responsive disorders WP4228,0.502729747375486,1.7472543781537548,1.2015912648483227,['AASS'],0.9999913070358183,0,0,1
238,Genotoxicity pathway WP4286,0.5120704374505346,1.0483251451540867,0.7016367759967826,"['CDKN1A', 'RPS27', 'EI24', 'ID2', 'PCDH8', 'TRIAP1', 'TRIM22', 'PHLDA3']",0.9999913070358183,0,0,8
239,Eukaryotic Transcription Initiation WP405,0.519336487363333,1.0483035714285713,0.6868519258660278,"['TAF13', 'TAF9', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.9999913070358183,0,0,7
240,Apoptosis WP254,0.5224259694456368,1.0277244558976921,0.6672727031179063,"['NFKBIA', 'JUN', 'BCL2L11', 'CRADD', 'CDKN2A', 'BAD', 'CYCS', 'FADD', 'NFKBIE', 'BCL2L2']",0.9999913070358183,0,0,10
241,EGF/EGFR signaling pathway WP437,0.5236420068088544,1.006294197031039,0.6510190332771651,"['VAV3', 'NDUFA13', 'JUN', 'JUND', 'PCNA', 'EGF', 'PRKCD', 'PEBP1', 'NEDD8', 'FOXO4', 'FOS', 'ELK1', 'EPN1', 'VAV2', 'RPS6KA2', 'CFL1', 'STMN1', 'AP2S1', 'FOSB', 'RAC1', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.9999913070358183,0,0,24
242,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.527766945357892,1.1231856378915201,0.7178284848941813,"['LTBP1', 'TGFBR1', 'MAPK3']",0.9999913070358183,0,0,3
243,Nanomaterial induced apoptosis WP2507,0.527766945357892,1.1231856378915201,0.7178284848941813,"['ENDOG', 'CYCS', 'FADD']",0.9999913070358183,0,0,3
244,Purinergic signaling WP4900,0.527766945357892,1.1231856378915201,0.7178284848941813,"['GNAZ', 'LPAR6', 'GNAS']",0.9999913070358183,0,0,3
245,G1 to S cell cycle control WP45,0.5369788497866674,1.022669092255907,0.6358921349561935,"['CDKN2D', 'CREB3', 'CDKN1A', 'CDKN1B', 'PCNA', 'CDKN2C', 'TFDP2', 'CDKN2A']",0.9999913070358183,0,0,8
246,Base Excision Repair WP4752,0.5380642876171486,1.0482604817127565,0.6496879800298239,"['FEN1', 'PCNA', 'NEIL2', 'POLD2', 'POLE3']",0.9999913070358183,0,0,5
247,Bladder cancer WP2828,0.5380642876171486,1.0482604817127565,0.6496879800298239,"['CDKN1A', 'EGF', 'CDKN2A', 'DAPK2', 'HRAS']",0.9999913070358183,0,0,5
248,GDNF/RET signaling axis WP4830,0.5462017142577299,1.1647611977233359,0.7044090553969511,"['GFRA1', 'FAT4']",0.9999913070358183,0,0,2
249,GPR40 Pathway WP3958,0.5462017142577299,1.1647611977233359,0.7044090553969511,"['PLCH1', 'PLCB2']",0.9999913070358183,0,0,2
250,RalA downstream regulated genes WP2290,0.5462017142577299,1.1647611977233359,0.7044090553969511,"['RAC1', 'HRAS']",0.9999913070358183,0,0,2
251,RAS and bradykinin pathways in COVID-19 WP4969,0.5462017142577299,1.1647611977233359,0.7044090553969511,"['F12', 'KLKB1']",0.9999913070358183,0,0,2
252,22q11.2 copy number variation syndrome WP4657,0.5634592357633376,0.9873172187406745,0.5663846813007049,"['RTN4R', 'SERPIND1', 'RTN4', 'SLC7A4', 'CYP26B1', 'MRPL40', 'ACTC1', 'THAP7', 'CLTCL1', 'DGCR6L', 'HIST1H4C', 'RAN', 'FGF10']",0.9999913070358183,0,0,13
253,Apoptosis Modulation by HSP70 WP384,0.5685485242125877,1.048217468805704,0.5918955059295362,"['CYCS', 'FADD', 'HSPA1A']",0.9999913070358183,0,0,3
254,IL-2 signaling pathway WP49,0.5689815564590914,1.007856995814177,0.5683378763132475,"['JUN', 'RPS6', 'FOS', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,5
255,IL-4 signaling pathway WP395,0.5717256879892307,0.9914695945945946,0.5543266538066913,"['NFKBIA', 'CEBPA', 'CEBPB', 'BAD', 'FOS', 'ELK1', 'MAPK3']",0.9999913070358183,0,0,7
256,Endometrial cancer WP4155,0.575097219208516,0.982573726541555,0.54357567923479,"['CDKN1A', 'GADD45B', 'BAD', 'EGF', 'FOS', 'FGF1', 'ELK1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,9
257,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.5824332847661369,1.3103294746215495,0.708286323246859,['SPI1'],0.9999913070358183,0,0,1
258,Complement Activation WP545,0.5824332847661369,1.3103294746215495,0.708286323246859,['C2'],0.9999913070358183,0,0,1
259,Cytokines and Inflammatory Response WP530,0.5824332847661369,1.3103294746215495,0.708286323246859,['IL7'],0.9999913070358183,0,0,1
260,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.5824332847661369,1.3103294746215495,0.708286323246859,['CDKN1A'],0.9999913070358183,0,0,1
261,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5824332847661369,1.3103294746215495,0.708286323246859,['EGF'],0.9999913070358183,0,0,1
262,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5824332847661369,1.3103294746215495,0.708286323246859,['HEY1'],0.9999913070358183,0,0,1
263,PTF1A related regulatory pathway WP4147,0.5824332847661369,1.3103294746215495,0.708286323246859,['FGF10'],0.9999913070358183,0,0,1
264,Small Ligand GPCRs WP247,0.5824332847661369,1.3103294746215495,0.708286323246859,['PTGER3'],0.9999913070358183,0,0,1
265,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.5824332847661369,1.3103294746215495,0.708286323246859,['MAPK3'],0.9999913070358183,0,0,1
266,Lung fibrosis WP3624,0.5851144564353211,0.9982379041674628,0.535003407478621,"['MT2A', 'CEBPB', 'EGF', 'FGF1']",0.9999913070358183,0,0,4
267,AGE/RAGE pathway WP2324,0.5852119226255436,0.974936900817433,0.5223528981831834,"['NFKBIA', 'JUN', 'PRKCD', 'CYCS', 'RAC1', 'FOXO4', 'MAPK3', 'SOD1']",0.9999913070358183,0,0,8
268,Pyrimidine metabolism WP4022,0.5900378198967383,0.9673515745998967,0.5103443571449797,"['POLD2', 'POLE3', 'NME2', 'POLR3H', 'POLR2I', 'DCK', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.9999913070358183,0,0,12
269,Cancer immunotherapy by PD-1 blockade WP4585,0.5954823454795295,1.0481959910913141,0.5433675455157844,"['JUN', 'NFATC2']",0.9999913070358183,0,0,2
270,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5954823454795295,1.0481959910913141,0.5433675455157844,"['RYR1', 'CCK']",0.9999913070358183,0,0,2
271,Ganglio Sphingolipid Metabolism WP1423,0.5954823454795295,1.0481959910913141,0.5433675455157844,"['B3GALT1', 'FUT1']",0.9999913070358183,0,0,2
272,NOTCH1 regulation of endothelial cell calcification WP3413,0.5954823454795295,1.0481959910913141,0.5433675455157844,"['JAG1', 'DLL3']",0.9999913070358183,0,0,2
273,Folate Metabolism WP176,0.5987912213547079,0.9704463607228996,0.49768593098612784,"['AHCY', 'GPX4', 'GPX3', 'RFK', 'SOD1']",0.9999913070358183,0,0,5
274,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5987912213547079,0.9704463607228996,0.49768593098612784,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,5
275,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6060743639730221,0.963296229988843,0.48237307980635646,"['CDKN1A', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'LAMA4', 'LAMA3', 'FGF1', 'HSP90B1', 'PPP2CA', 'GYS1', 'GNG10', 'GNG3', 'PPP2R1A', 'PDGFD', 'PELO', 'HRAS', 'EIF4B', 'MAPK3', 'HSP90AA1', 'EGF', 'BAD', 'RPS6', 'GNG13', 'EFNA1', 'FGF17', 'CREB3', 'EFNA3', 'LPAR6', 'GNB2', 'DDIT4', 'ITGA8', 'FGF10']",0.9999913070358183,0,0,32
276,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6070766299464632,0.982620320855615,0.4904260499134642,"['BCL2L11', 'BAD', 'FADD']",0.9999913070358183,0,0,3
277,Nucleotide metabolism WP404,0.6070766299464632,0.982620320855615,0.4904260499134642,"['PRPS1', 'NME2', 'OAZ1']",0.9999913070358183,0,0,3
278,Striated Muscle Contraction Pathway WP383,0.6070766299464632,0.982620320855615,0.4904260499134642,"['MYOM1', 'ACTC1', 'ACTG1']",0.9999913070358183,0,0,3
279,Oxysterols derived from cholesterol WP4545,0.6176691314794129,0.9527823937097232,0.4590527971381437,"['CYP39A1', 'DBP', 'EPHX2', 'ACOT6']",0.9999913070358183,0,0,4
280,Wnt Signaling Pathway WP363,0.6212650022320704,0.9404647435897436,0.44765891700841254,"['PRKCG', 'GSK3A', 'FRAT1', 'NFATC2', 'PPARG', 'ROR1', 'RAC1']",0.9999913070358183,0,0,7
281,Non-small cell lung cancer WP4255,0.6284130730093669,0.9355642122740916,0.43462343626014244,"['PRKCG', 'CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'EGF', 'CYCS', 'HRAS', 'FHIT', 'MAPK3']",0.9999913070358183,0,0,10
282,Histone Modifications WP2369,0.636408172222405,0.9246397354122372,0.4178586966535693,"['SET', 'H3F3B', 'SUV39H1', 'H3F3A', 'HIST1H4C', 'EZH2']",0.9999913070358183,0,0,6
283,Pathways Regulating Hippo Signaling WP4540,0.6372865086193487,0.9294679439090542,0.41875871982951457,"['PRKCG', 'CDH4', 'PRKCH', 'PRKAR1A', 'FLT3', 'PRKCD', 'GNAS', 'PRKCQ', 'RAC1', 'PLCB2', 'CDH7']",0.9999913070358183,0,0,11
284,Phytochemical activity on NRF2 transcriptional activation WP3,0.6406288864004076,0.9528244583923872,0.4242974478961181,"['CEBPB', 'SLC7A11']",0.9999913070358183,0,0,2
285,PPAR-alpha pathway WP2878,0.6406288864004076,0.9528244583923872,0.4242974478961181,"['CPT1A', 'PPARA']",0.9999913070358183,0,0,2
286,TP53 network WP1742,0.6406288864004076,0.9528244583923872,0.4242974478961181,"['CDKN1A', 'CDKN2A']",0.9999913070358183,0,0,2
287,1q21.1 copy number variation syndrome WP4905,0.6432373867595115,0.9247404844290658,0.40803381985552745,"['PYGO1', 'PYGO2', 'ACP6']",0.9999913070358183,0,0,3
288,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6432373867595115,0.9247404844290658,0.40803381985552745,"['MDH2', 'SCO2', 'HMGA1']",0.9999913070358183,0,0,3
289,Urea cycle and associated pathways WP4595,0.6432373867595115,0.9247404844290658,0.40803381985552745,"['LDHB', 'MDH2', 'ARG1']",0.9999913070358183,0,0,3
290,Leptin signaling pathway WP2034,0.6480850736028649,0.9190723792046052,0.3986323004039476,"['GSK3A', 'BAD', 'CFL2', 'RPS6', 'LEPR', 'RAC1', 'ELK1', 'HRAS', 'ACACB', 'MAPK3']",0.9999913070358183,0,0,10
291,GABA receptor Signaling WP4159,0.6485727660768725,0.9112795363352653,0.39456679305937076,"['AP2S1', 'GABRD', 'GABRG3', 'AP2M1']",0.9999913070358183,0,0,4
292,Intraflagellar transport proteins binding to dynein WP4532,0.6485727660768725,0.9112795363352653,0.39456679305937076,"['DYNLT3', 'DYNLRB1', 'DYNLL1', 'DYNLL2']",0.9999913070358183,0,0,4
293,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6485727660768725,0.9112795363352653,0.39456679305937076,"['CDKN1B', 'BAD', 'FOXO4', 'HRAS']",0.9999913070358183,0,0,4
294,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.6493665056835306,1.0481745325022263,0.4525577376773852,['BCL2L11'],0.9999913070358183,0,0,1
295,Drug Induction of Bile Acid Pathway WP2289,0.6493665056835306,1.0481745325022263,0.4525577376773852,['SLC51A'],0.9999913070358183,0,0,1
296,EDA signaling in hair follicle development WP3930,0.6493665056835306,1.0481745325022263,0.4525577376773852,['SOSTDC1'],0.9999913070358183,0,0,1
297,miRNA Biogenesis WP2338,0.6493665056835306,1.0481745325022263,0.4525577376773852,['RAN'],0.9999913070358183,0,0,1
298,Peroxiredoxin 2 induced ovarian failure WP4873,0.6493665056835306,1.0481745325022263,0.4525577376773852,['PRDX2'],0.9999913070358183,0,0,1
299,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.6493665056835306,1.0481745325022263,0.4525577376773852,['NFKBIA'],0.9999913070358183,0,0,1
300,ATM Signaling Pathway WP2516,0.6547379034336509,0.9033652219385401,0.3825934834779982,"['NFKBIA', 'CDKN1A', 'JUN', 'CRADD', 'H2AFX']",0.9999913070358183,0,0,5
301,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6671671179743208,0.9031492300340666,0.36551778121600004,"['CREB3', 'TPO', 'THRA', 'BAD', 'RPS6', 'ZNF516', 'ITPR2', 'PRKCQ', 'PPARG', 'HRAS']",0.9999913070358183,0,0,10
302,Endoderm differentiation WP2853,0.6677103777134342,0.9135096274068517,0.36896723803856657,"['VAV3', 'DUSP4', 'DUSP2', 'CTBP2', 'SLC2A12', 'ZFHX4', 'NME1', 'TOX3', 'TRIM5', 'C1QBP', 'TCEAL2', 'PAF1', 'PLCH1', 'TOX', 'EZH2']",0.9999913070358183,0,0,15
303,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6769773224227551,0.8732917409387998,0.3406863940561609,"['FSHR', 'RPS6', 'MAPK3']",0.9999913070358183,0,0,3
304,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6769773224227551,0.8732917409387998,0.3406863940561609,"['FZD1', 'PLOD2', 'PPIB']",0.9999913070358183,0,0,3
305,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6777676556060889,0.8732352504086789,0.339645497382073,"['HEXIM1', 'NFKBIA', 'SUPT4H1', 'NFATC2']",0.9999913070358183,0,0,4
306,Tumor suppressor activity of SMARCB1 WP4204,0.6777676556060889,0.8732352504086789,0.339645497382073,"['H3F3B', 'CDKN2A', 'H3F3A', 'EZH2']",0.9999913070358183,0,0,4
307,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6797576274203591,0.8894987101016744,0.34336337999261385,"['EGR1', 'JUN', 'CDKN1B', 'RPS6', 'GNAS', 'FOS', 'HRAS', 'MYL12B', 'MAPK3']",0.9999913070358183,0,0,9
308,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.6817003632046181,0.8733481811432814,0.3346365150591841,"['PPARA', 'LTB4R']",0.9999913070358183,0,0,2
309,Eicosanoid Synthesis WP167,0.6817003632046181,0.8733481811432814,0.3346365150591841,"['PTGES2', 'PTGES']",0.9999913070358183,0,0,2
310,Imatinib and Chronic Myeloid Leukemia WP3640,0.6817003632046181,0.8733481811432814,0.3346365150591841,"['SPRED2', 'CDKN1B']",0.9999913070358183,0,0,2
311,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.6817003632046181,0.8733481811432814,0.3346365150591841,"['EGLN2', 'BCL2L2']",0.9999913070358183,0,0,2
312,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6817003632046181,0.8733481811432814,0.3346365150591841,"['NFKBIA', 'NFKBIE']",0.9999913070358183,0,0,2
313,Type II diabetes mellitus WP1584,0.6817003632046181,0.8733481811432814,0.3346365150591841,"['KCNJ11', 'PRKCD']",0.9999913070358183,0,0,2
314,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.684746717324867,0.8731221181020378,0.3306568160838585,"['CEBPA', 'CDKN1A', 'CEBPB', 'PPARG', 'JUNB', 'ACTB']",0.9999913070358183,0,0,6
315,Glioblastoma signaling pathways WP2261,0.6913258449093712,0.8863423696160727,0.3271879772413703,"['PRKCG', 'CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2C', 'CDKN2A', 'PRKCD', 'PRKCQ', 'FOXO4', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,11
316,Toll-like Receptor Signaling Pathway WP75,0.6939116091611793,0.8730087836831919,0.31900674281436125,"['NFKBIA', 'JUN', 'TOLLIP', 'MAP3K8', 'FADD', 'RAC1', 'FOS', 'MAPK3']",0.9999913070358183,0,0,8
317,ErbB signaling pathway WP673,0.6968353763012272,0.8851498251252481,0.31972150303345204,"['PRKCG', 'SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'BCL2L11', 'BAD', 'EGF', 'NRG1', 'ELK1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,12
318,Autophagy WP4923,0.7052253258099369,0.8382345073562193,0.2927432725997106,"['MAP1LC3B', 'DEPTOR', 'ATG101', 'ATG9A']",0.9999913070358183,0,0,4
319,Aspirin and miRNAs WP4707,0.7055747369707759,0.873404571089344,0.3045933622332605,['PPARA'],0.9999913070358183,0,0,1
320,Cell Differentiation - Index WP2029,0.7055747369707759,0.873404571089344,0.3045933622332605,['MEF2D'],0.9999913070358183,0,0,1
321,"Cerebral organic acidurias, including diseases WP4519",0.7055747369707759,0.873404571089344,0.3045933622332605,['MDH2'],0.9999913070358183,0,0,1
322,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.7055747369707759,0.873404571089344,0.3045933622332605,['DHCR24'],0.9999913070358183,0,0,1
323,Disorders of the Krebs cycle WP4236,0.7055747369707759,0.873404571089344,0.3045933622332605,['SUCLG2'],0.9999913070358183,0,0,1
324,Estrogen metabolism WP697,0.7055747369707759,0.873404571089344,0.3045933622332605,['ARSE'],0.9999913070358183,0,0,1
325,Insulin signaling in adipocytes (diabetic condition) WP3635,0.7055747369707759,0.873404571089344,0.3045933622332605,['RPS6'],0.9999913070358183,0,0,1
326,Insulin signaling in adipocytes (normal condition) WP3634,0.7055747369707759,0.873404571089344,0.3045933622332605,['RPS6'],0.9999913070358183,0,0,1
327,Methylation Pathways WP704,0.7055747369707759,0.873404571089344,0.3045933622332605,['MAT2B'],0.9999913070358183,0,0,1
328,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.7055747369707759,0.873404571089344,0.3045933622332605,['JUN'],0.9999913070358183,0,0,1
329,Supression of HMGB1 mediated inflammation by THBD WP4479,0.7055747369707759,0.873404571089344,0.3045933622332605,['NFKBIA'],0.9999913070358183,0,0,1
330,Urea cycle and related diseases WP4571,0.7055747369707759,0.873404571089344,0.3045933622332605,['ARG1'],0.9999913070358183,0,0,1
331,DNA Mismatch Repair WP531,0.7082923835936705,0.8272586546580355,0.2853201031224342,"['PCNA', 'POLD2', 'POLE3']",0.9999913070358183,0,0,3
332,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7082923835936705,0.8272586546580355,0.2853201031224342,"['H3F3B', 'SUV39H1', 'H3F3A']",0.9999913070358183,0,0,3
333,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7100291155463341,0.8526889534883721,0.2920027369245984,"['KIRREL3', 'CDKN1A', 'CDKN1B', 'TRPC6', 'PCNA', 'JAG1', 'YWHAQ']",0.9999913070358183,0,0,7
334,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.718843006395586,0.8060990234709611,0.26610319866710397,"['PPARG', 'PPARA']",0.9999913070358183,0,0,2
335,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7286722943690556,0.8270274078771225,0.2617799577148903,"['XBP1', 'HSPA5', 'PPP1R1A', 'DDIT3', 'PPP1R1B', 'PPP1R9B']",0.9999913070358183,0,0,6
336,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.7286722943690556,0.8270274078771225,0.2617799577148903,"['NFKBIA', 'TOLLIP', 'MAP3K8', 'FOS', 'ELK1', 'MAPK3']",0.9999913070358183,0,0,6
337,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7286722943690556,0.8270274078771225,0.2617799577148903,"['EIF4A2', 'RPS6KA2', 'PRKCD', 'RPS6', 'EIF4B', 'MAPK3']",0.9999913070358183,0,0,6
338,MAPK Cascade WP422,0.7309423805775705,0.805926129153949,0.2525938872849166,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,4
339,miRNA regulation of prostate cancer signaling pathways WP3981,0.7309423805775705,0.805926129153949,0.2525938872849166,"['NFKBIA', 'CDKN1A', 'CDKN1B', 'BAD']",0.9999913070358183,0,0,4
340,Neural Crest Cell Migration during Development WP4564,0.7309423805775705,0.805926129153949,0.2525938872849166,"['ARF1', 'JUN', 'RAC1', 'FOS']",0.9999913070358183,0,0,4
341,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7309423805775705,0.805926129153949,0.2525938872849166,"['NFKBIA', 'TEC', 'RPS6', 'MAPK3']",0.9999913070358183,0,0,4
342,Mesodermal commitment pathway WP2857,0.7361384202204411,0.8623271252074497,0.2641627968104824,"['VAV3', 'CTBP2', 'SLC2A12', 'ZFHX4', 'PPP2CA', 'TOX3', 'ARL4A', 'PRKAR1A', 'TRIM5', 'C1QBP', 'BHLHE40', 'RPL38', 'PLCH1', 'TOX']",0.9999913070358183,0,0,14
343,Signal transduction through IL1R WP4496,0.7372180478270471,0.7858288770053476,0.2395768849751707,"['NFKBIA', 'JUN', 'TOLLIP']",0.9999913070358183,0,0,3
344,Wnt signaling in kidney disease WP4150,0.7372180478270471,0.7858288770053476,0.2395768849751707,"['FZD1', 'WNT7A', 'WNT2']",0.9999913070358183,0,0,3
345,Regulation of toll-like receptor signaling pathway WP1449,0.7401872572576099,0.8470219930548248,0.2548283237133179,"['NFKBIA', 'JUN', 'TOLLIP', 'PELI3', 'PELI2', 'MAP3K8', 'FADD', 'RAC1', 'FOS', 'TMED7', 'MAPK3']",0.9999913070358183,0,0,11
346,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7522608102501249,0.7484568883232581,0.21306486377995965,"['PRXL2B', 'PTGES']",0.9999913070358183,0,0,2
347,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.7522608102501249,0.7484568883232581,0.21306486377995965,"['FASN', 'PPARA']",0.9999913070358183,0,0,2
348,Statin inhibition of cholesterol production WP430,0.7522608102501249,0.7484568883232581,0.21306486377995965,"['ABCG8', 'LPL']",0.9999913070358183,0,0,2
349,Urea cycle and metabolism of amino groups WP497,0.7522608102501249,0.7484568883232581,0.21306486377995965,"['ARG1', 'CKB']",0.9999913070358183,0,0,2
350,Biomarkers for urea cycle disorders WP4583,0.752775843662411,0.7485688843658568,0.2125844155570368,['ARG1'],0.9999913070358183,0,0,1
351,"Degradation pathway of sphingolipids, including diseases WP4153",0.752775843662411,0.7485688843658568,0.2125844155570368,['NEU1'],0.9999913070358183,0,0,1
352,Farnesoid X receptor pathway WP2879,0.752775843662411,0.7485688843658568,0.2125844155570368,['FKBP5'],0.9999913070358183,0,0,1
353,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.752775843662411,0.7485688843658568,0.2125844155570368,['ELOB'],0.9999913070358183,0,0,1
354,Iron metabolism in placenta WP2007,0.752775843662411,0.7485688843658568,0.2125844155570368,['FTH1'],0.9999913070358183,0,0,1
355,Mitochondrial CII Assembly WP4920,0.752775843662411,0.7485688843658568,0.2125844155570368,['SDHAF1'],0.9999913070358183,0,0,1
356,Vitamin B12 Disorders WP4271,0.752775843662411,0.7485688843658568,0.2125844155570368,['CUBN'],0.9999913070358183,0,0,1
357,Pancreatic adenocarcinoma pathway WP4263,0.7552703305089574,0.834675014907573,0.23427619937128577,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'EGF', 'PRKCD', 'PEBP1', 'RAC1', 'TGFBR1', 'DUSP6', 'MAPK3']",0.9999913070358183,0,0,11
358,Small cell lung cancer WP4658,0.7552703305089574,0.834675014907573,0.23427619937128577,"['NFKBIA', 'CDKN1A', 'CDKN1B', 'GADD45B', 'LAMA4', 'LAMA3', 'CKS2', 'CYCS', 'FHIT', 'CKS1B', 'SKP1']",0.9999913070358183,0,0,11
359,ESC Pluripotency Pathways WP3931,0.7577284564536346,0.8376554809843401,0.23239092292173397,"['FZD1', 'FGF17', 'JUN', 'EGF', 'WNT7A', 'FOS', 'FGF1', 'ELK1', 'WNT2', 'FGF23', 'HRAS', 'FGF10']",0.9999913070358183,0,0,12
360,Neovascularisation processes WP4331,0.7638206024773749,0.7483447924624396,0.20162079830204355,"['JAG1', 'TGFBR1', 'MAPK3']",0.9999913070358183,0,0,3
361,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7682123476164189,0.8180599016540009,0.21571347083609835,"['PRKCG', 'SHC4', 'BCL2L11', 'BAD', 'EGF', 'PDGFD', 'RPS6', 'NRG1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,10
362,Target Of Rapamycin (TOR) Signaling WP1471,0.7772429937046754,0.7482325966498949,0.18855629361020712,"['FKBP1A', 'RRAGA', 'DDIT4', 'RAC1']",0.9999913070358183,0,0,4
363,Ebstein-Barr virus LMP1 signaling WP262,0.7821932814861247,0.6985003711952487,0.17158899524203863,"['NFKBIA', 'HSP90AA1']",0.9999913070358183,0,0,2
364,Hippo-Yap signaling pathway WP4537,0.7821932814861247,0.6985003711952487,0.17158899524203863,"['YWHAQ', 'NDRG1']",0.9999913070358183,0,0,2
365,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7821932814861247,0.6985003711952487,0.17158899524203863,"['HRAS', 'MAPK3']",0.9999913070358183,0,0,2
366,Purine metabolism and related disorders WP4224,0.7821932814861247,0.6985003711952487,0.17158899524203863,"['PRPS1', 'APRT']",0.9999913070358183,0,0,2
367,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.7821932814861247,0.6985003711952487,0.17158899524203863,"['PYGO1', 'FLT3']",0.9999913070358183,0,0,2
368,Glycosylation and related congenital defects WP4521,0.7881895871113526,0.7142683519688867,0.1700077426807669,"['DPM3', 'PMM2', 'MGAT2']",0.9999913070358183,0,0,3
369,Resistin as a regulator of inflammation WP4481,0.7881895871113526,0.7142683519688867,0.1700077426807669,"['NFKBIA', 'PLCB2', 'MAPK3']",0.9999913070358183,0,0,3
370,Biotin Metabolism (including IEMs) WP5031,0.7924126364132682,0.6549421193232413,0.15238735904124898,['ACACB'],0.9999913070358183,0,0,1
371,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.7924126364132682,0.6549421193232413,0.15238735904124898,['TOB1'],0.9999913070358183,0,0,1
372,Cancer immunotherapy by CTLA4 blockade WP4582,0.7924126364132682,0.6549421193232413,0.15238735904124898,['PPP2CA'],0.9999913070358183,0,0,1
373,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7924126364132682,0.6549421193232413,0.15238735904124898,['SPARC'],0.9999913070358183,0,0,1
374,Amyotrophic lateral sclerosis (ALS) WP2447,0.7979109461577192,0.7223699786308362,0.16308100682727536,"['BAD', 'NEFL', 'RAC1', 'SOD1']",0.9999913070358183,0,0,4
375,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7979109461577192,0.7223699786308362,0.16308100682727536,"['ACTC1', 'YWHAQ', 'ACTB', 'ACTG1']",0.9999913070358183,0,0,4
376,Neural Crest Cell Migration in Cancer WP4565,0.7979109461577192,0.7223699786308362,0.16308100682727536,"['ARF1', 'JUN', 'RAC1', 'FOS']",0.9999913070358183,0,0,4
377,MET in type 1 papillary renal cell carcinoma WP4205,0.7997458079178643,0.7635416666666667,0.170622045435211,"['CDKN1A', 'JUN', 'BAD', 'RPL11', 'RAC1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,7
378,Notch Signaling Pathway Netpath WP61,0.8030951385917077,0.7480079046344107,0.16402473899095038,"['PSENEN', 'CDKN1A', 'JAG1', 'HEY1', 'SKP1', 'DLL3']",0.9999913070358183,0,0,6
379,PPAR signaling pathway WP3942,0.8084829158605688,0.7272772326295965,0.1546160348009068,"['CPT1A', 'FABP7', 'LPL', 'PPARG', 'PPARA']",0.9999913070358183,0,0,5
380,Immune response to tuberculosis WP4197,0.8088988313358006,0.6547884187082406,0.1388684600727834,"['TAP1', 'IFIT1']",0.9999913070358183,0,0,2
381,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8088988313358006,0.6547884187082406,0.1388684600727834,"['B3GALT1', 'ST6GALNAC3']",0.9999913070358183,0,0,2
382,Monoamine Transport WP727,0.8088988313358006,0.6547884187082406,0.1388684600727834,"['TDO2', 'SYN1']",0.9999913070358183,0,0,2
383,NAD+ biosynthetic pathways WP3645,0.8088988313358006,0.6547884187082406,0.1388684600727834,"['TDO2', 'ACMSD']",0.9999913070358183,0,0,2
384,Vitamin D in inflammatory diseases WP4482,0.8088988313358006,0.6547884187082406,0.1388684600727834,"['NFKBIA', 'DUSP1']",0.9999913070358183,0,0,2
385,Glycerophospholipid Biosynthetic Pathway WP2533,0.8104313498011961,0.6831550802139037,0.1435914388868343,"['PTPMT1', 'GPAT3', 'CDIPT']",0.9999913070358183,0,0,3
386,The influence of laminopathies on Wnt signaling WP4844,0.8104313498011961,0.6831550802139037,0.1435914388868343,"['CEBPA', 'CEBPB', 'PPARG']",0.9999913070358183,0,0,3
387,DNA Replication WP466,0.8170006548100259,0.6982315351463814,0.14112333389839984,"['PCNA', 'UBC', 'POLD2', 'UBA52']",0.9999913070358183,0,0,4
388,Nephrotic syndrome WP4758,0.8170006548100259,0.6982315351463814,0.14112333389839984,"['CUBN', 'TRPC6', 'ARHGDIA', 'PMM2']",0.9999913070358183,0,0,4
389,Insulin Signaling WP481,0.8193644309864803,0.8237486254945567,0.16411241007931127,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'PRKCD', 'FOS', 'ELK1', 'EHD2', 'GYS1', 'PFKL', 'RPS6KA2', 'MAP3K8', 'PRKCQ', 'RAC1', 'HRAS', 'VAMP2', 'ARF6', 'MAPK3']",0.9999913070358183,0,0,20
390,DNA damage response (only ATM dependent) WP710,0.8215803869503129,0.7779456558526326,0.15288615309782908,"['FRAT1', 'JUN', 'CDKN1A', 'BCL2L11', 'CDKN1B', 'CDKN2A', 'BAD', 'WNT7A', 'RAC1', 'WNT2', 'HRAS']",0.9999913070358183,0,0,11
391,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.8256968952662052,0.5821213020678737,0.11149225380022344,['GRM4'],0.9999913070358183,0,0,1
392,Hedgehog Signaling Pathway Netpath WP47,0.8256968952662052,0.5821213020678737,0.11149225380022344,['SAP18'],0.9999913070358183,0,0,1
393,Osteoclast Signaling WP12,0.8256968952662052,0.5821213020678737,0.11149225380022344,['ATP6V1G1'],0.9999913070358183,0,0,1
394,Osteopontin Signaling WP1434,0.8256968952662052,0.5821213020678737,0.11149225380022344,['MAPK3'],0.9999913070358183,0,0,1
395,Focal Adhesion WP306,0.828355778122176,0.8172429277054333,0.1538970859249867,"['PRKCG', 'VAV3', 'SHC4', 'JUN', 'EGF', 'BAD', 'TXK', 'LAMA4', 'LAMA3', 'ELK1', 'ACTB', 'MYL12B', 'VAV2', 'ACTG1', 'PDGFD', 'ITGA8', 'FLNB', 'RAC1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,20
396,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.830663636553939,0.6546345811051694,0.12145457350019229,"['NFKBIA', 'JUN', 'FOS']",0.9999913070358183,0,0,3
397,Gastric Cancer Network 1 WP2361,0.8326425743732987,0.6162190488667627,0.11286101872766453,"['H3F3A', 'GATD3A']",0.9999913070358183,0,0,2
398,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8326425743732987,0.6162190488667627,0.11286101872766453,"['FZD1', 'FGF1']",0.9999913070358183,0,0,2
399,Regulation of Actin Cytoskeleton WP51,0.8332265882483348,0.7971484066508719,0.14543945504612013,"['CHRM1', 'EGF', 'CHRM5', 'BRK1', 'FGF1', 'ACTB', 'ACTG1', 'FGF17', 'CFL2', 'TMSB4X', 'CFL1', 'RAC1', 'PFN1', 'FGF23', 'FGF10', 'MAPK3']",0.9999913070358183,0,0,16
400,Netrin-UNC5B signaling pathway WP4747,0.8345806902097699,0.6756504105964075,0.12217505822671478,"['JUN', 'RAC1', 'NTN1', 'MAPK3']",0.9999913070358183,0,0,4
401,Ras signaling WP4223,0.8358977846953819,0.8079250047437638,0.14481970109041015,"['PRKCG', 'SHC4', 'RASA4B', 'FLT3', 'BAD', 'RASAL1', 'FOXO4', 'ELK1', 'GNG13', 'GNG10', 'GNG3', 'GNB2', 'CALM3', 'RAC1', 'CALM1', 'CALM2', 'HRAS', 'ARF6', 'MAPK3']",0.9999913070358183,0,0,19
402,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8407215350886005,0.6888821071411804,0.1195174534167668,"['ADCY10', 'CFL1', 'BANF1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,5
403,AMP-activated protein kinase (AMPK) signaling WP1403,0.8424243614591816,0.7184436274509803,0.12319253423891441,"['GYS1', 'CDKN1A', 'CPT1A', 'FASN', 'LEPR', 'EEF2', 'ACACB']",0.9999913070358183,0,0,7
404,Cysteine and methionine catabolism WP4504,0.8536463495063172,0.5238646482635797,0.08289544173714222,['AHCY'],0.9999913070358183,0,0,1
405,FOXA2 pathway WP5066,0.8536463495063172,0.5238646482635797,0.08289544173714222,['FASN'],0.9999913070358183,0,0,1
406,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.8536463495063172,0.5238646482635797,0.08289544173714222,['JAG1'],0.9999913070358183,0,0,1
407,Homologous recombination WP186,0.8536463495063172,0.5238646482635797,0.08289544173714222,['POLD2'],0.9999913070358183,0,0,1
408,Leptin Insulin Overlap WP3935,0.8536463495063172,0.5238646482635797,0.08289544173714222,['LEPR'],0.9999913070358183,0,0,1
409,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.8536463495063172,0.5238646482635797,0.08289544173714222,['NFKBIA'],0.9999913070358183,0,0,1
410,"NAD metabolism, sirtuins and aging WP3630",0.8536463495063172,0.5238646482635797,0.08289544173714222,['PPARG'],0.9999913070358183,0,0,1
411,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8536875496743462,0.5819351645632269,0.09205633475709642,"['CEBPA', 'CEBPB']",0.9999913070358183,0,0,2
412,NRF2-ARE regulation WP4357,0.8536875496743462,0.5819351645632269,0.09205633475709642,"['CEBPB', 'SLC7A11']",0.9999913070358183,0,0,2
413,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8536875496743462,0.5819351645632269,0.09205633475709642,"['PRKCG', 'PLCB2']",0.9999913070358183,0,0,2
414,SARS-CoV-2 mitochondrial interactions WP5038,0.8536875496743462,0.5819351645632269,0.09205633475709642,"['PHB', 'PHB2']",0.9999913070358183,0,0,2
415,Signal Transduction of S1P Receptor WP26,0.8536875496743462,0.5819351645632269,0.09205633475709642,"['PLCB2', 'MAPK3']",0.9999913070358183,0,0,2
416,Vitamin B12 metabolism WP1533,0.8536875496743462,0.5819351645632269,0.09205633475709642,"['CUBN', 'SOD1']",0.9999913070358183,0,0,2
417,Phosphodiesterases in neuronal function WP4222,0.855086795206425,0.6711612799926805,0.1050718422795404,"['ADCY10', 'PDE11A', 'PDE10A', 'PPP1R1B', 'GRIN2D']",0.9999913070358183,0,0,5
418,TGF-beta Signaling Pathway WP366,0.860639764019034,0.7628004179728317,0.11448051817581487,"['KLF10', 'JUN', 'CDKN1A', 'JUND', 'CITED1', 'NEDD9', 'FOS', 'TGFBR1', 'PJA1', 'PARD6A', 'FOSB', 'RAC1', 'JUNB', 'SKP1']",0.9999913070358183,0,0,14
419,Melatonin metabolism and effects WP3298,0.8656017492892057,0.6041752365281777,0.08720082334586858,"['PER2', 'CALM1', 'CALM2']",0.9999913070358183,0,0,3
420,Head and Neck Squamous Cell Carcinoma WP4674,0.8665960530632499,0.6912146226415095,0.09896971618726724,"['FKBP1A', 'CDKN1A', 'CDKN2A', 'RPS6', 'DDIT4', 'FADD', 'HRAS']",0.9999913070358183,0,0,7
421,Fatty Acid Biosynthesis WP357,0.8722885806320932,0.5512601101863791,0.07532140791754001,"['FASN', 'ACACB']",0.9999913070358183,0,0,2
422,Glycerolipids and Glycerophospholipids WP4722,0.8722885806320932,0.5512601101863791,0.07532140791754001,"['DGAT2', 'CDIPT']",0.9999913070358183,0,0,2
423,Canonical and non-canonical TGF-B signaling WP3874,0.877115740875692,0.47620011333279366,0.06243760724628065,['TGFBR1'],0.9999913070358183,0,0,1
424,Overview of nanoparticle effects WP3287,0.877115740875692,0.47620011333279366,0.06243760724628065,['LAMA3'],0.9999913070358183,0,0,1
425,Serotonin and anxiety WP3947,0.877115740875692,0.47620011333279366,0.06243760724628065,['FOS'],0.9999913070358183,0,0,1
426,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.877115740875692,0.47620011333279366,0.06243760724628065,['MAPK3'],0.9999913070358183,0,0,1
427,Chemokine signaling pathway WP3929,0.8785442849083519,0.7390331244404655,0.09569663286241444,"['SHC4', 'VAV3', 'PRKCD', 'GNG13', 'VAV2', 'NFKBIA', 'GNG10', 'GNG3', 'GNB2', 'RAC1', 'HRAS', 'PLCB2', 'MAPK3']",0.9999913070358183,0,0,13
428,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8785442849083519,0.7390331244404655,0.09569663286241444,"['FZD1', 'SPARC', 'JAG1', 'WNT7A', 'TGFBR1', 'DLL3', 'ID2', 'PKP2', 'WNT2', 'HRAS', 'MEF2D', 'EZH2', 'MAPK3']",0.9999913070358183,0,0,13
429,Interleukin-11 Signaling Pathway WP2332,0.8790258809545968,0.6158768456111825,0.0794117382247493,"['BGLAP', 'RPS6', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,4
430,Fatty acid beta-oxidation WP143,0.880563864648447,0.5817488611606259,0.07399427901097201,"['CPT1A', 'TPI1', 'LPL']",0.9999913070358183,0,0,3
431,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8826645140035388,0.6861962673617467,0.08564421748501715,"['FZD1', 'EGF', 'NRG1', 'RAC1', 'CALM1', 'PLCB2', 'CALM2', 'MAPK3']",0.9999913070358183,0,0,8
432,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8837021582986635,0.6541722445336903,0.08087871505621046,"['NFKBIA', 'BAD', 'STMN1', 'RAC1', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,6
433,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8886881548333081,0.523652561247216,0.0617956559125069,"['HRAS', 'TGFBR1']",0.9999913070358183,0,0,2
434,Endochondral Ossification with Skeletal Dysplasias WP4808,0.891343257611478,0.5982294121393542,0.06881174244854396,"['ACAN', 'THRA', 'CALM1', 'CALM2']",0.9999913070358183,0,0,4
435,Endochondral Ossification WP474,0.891343257611478,0.5982294121393542,0.06881174244854396,"['ACAN', 'THRA', 'CALM1', 'CALM2']",0.9999913070358183,0,0,4
436,Regulation of Microtubule Cytoskeleton WP2038,0.891343257611478,0.5982294121393542,0.06881174244854396,"['PARD6A', 'CFL2', 'STMN1', 'RAC1']",0.9999913070358183,0,0,4
437,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8918230467681703,0.6230618920181811,0.07133282586702995,"['NFKBIA', 'TKFC', 'PIN1', 'ISG15', 'FADD']",0.9999913070358183,0,0,5
438,Retinoblastoma gene in cancer WP2446,0.8919635610482534,0.6750709562160526,0.07718086112758019,"['CDKN1A', 'CDKN1B', 'PCNA', 'TFDP2', 'H2AFZ', 'SUV39H1', 'STMN1', 'DCK']",0.9999913070358183,0,0,8
439,DNA damage response WP707,0.8939825032287808,0.6407671502335874,0.07181018203018581,"['CDKN1A', 'CDKN1B', 'GADD45B', 'CDK5', 'H2AFX', 'CYCS']",0.9999913070358183,0,0,6
440,Biomarkers for pyrimidine metabolism disorders WP4584,0.8968229157439485,0.43647966755713863,0.04753126296303495,['CKB'],0.9999913070358183,0,0,1
441,Fatty acid transporters WP5061,0.8968229157439485,0.43647966755713863,0.04753126296303495,['FABP7'],0.9999913070358183,0,0,1
442,IL-9 signaling pathway WP22,0.8968229157439485,0.43647966755713863,0.04753126296303495,['MAPK3'],0.9999913070358183,0,0,1
443,miRNA targets in ECM and membrane receptors WP2911,0.8968229157439485,0.43647966755713863,0.04753126296303495,['LAMA4'],0.9999913070358183,0,0,1
444,Omega-9 FA synthesis WP4724,0.8968229157439485,0.43647966755713863,0.04753126296303495,['FASN'],0.9999913070358183,0,0,1
445,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8968229157439485,0.43647966755713863,0.04753126296303495,['LDHA'],0.9999913070358183,0,0,1
446,Transcription co-factors SKI and SKIL protein partners WP4533,0.8968229157439485,0.43647966755713863,0.04753126296303495,['MERTK'],0.9999913070358183,0,0,1
447,IL-1 signaling pathway WP195,0.9021402180312462,0.60852021658403,0.06266864840268016,"['NFKBIA', 'JUN', 'TOLLIP', 'PELI2', 'MAPK3']",0.9999913070358183,0,0,5
448,Cannabinoid receptor signaling WP3869,0.9031138340194471,0.4986743026832114,0.0508182383356963,"['PRKAR1A', 'MAPK3']",0.9999913070358183,0,0,2
449,Gastric Cancer Network 2 WP2363,0.9031138340194471,0.4986743026832114,0.0508182383356963,"['S100A6', 'CACYBP']",0.9999913070358183,0,0,2
450,MTHFR deficiency WP4288,0.9031138340194471,0.4986743026832114,0.0508182383356963,"['CYCS', 'GRIN2D']",0.9999913070358183,0,0,2
451,Thermogenesis WP4321,0.9054499672497708,0.6930566631463241,0.06883664539144661,"['ADCY10', 'CREB3', 'CPT1A', 'RPS6KA2', 'RPS6', 'ZNF516', 'GNAS', 'PPARG', 'HRAS', 'ACTB', 'ACTG1']",0.9999913070358183,0,0,11
452,Disruption of postsynaptic signaling by CNV WP4875,0.9061046443113681,0.5415360501567398,0.05339571348715012,"['YWHAG', 'MAPK3', 'GRIN2D']",0.9999913070358183,0,0,3
453,miRNA regulation of DNA damage response WP1530,0.9122287875073202,0.6155340315510408,0.05654569949585198,"['CDKN1A', 'CDKN1B', 'GADD45B', 'CDK5', 'H2AFX', 'CYCS']",0.9999913070358183,0,0,6
454,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.91337074228779,0.40287005959312283,0.03650543004684005,['FRAT1'],0.9999913070358183,0,0,1
455,Riboflavin and CoQ disorders WP5037,0.91337074228779,0.40287005959312283,0.03650543004684005,['RFK'],0.9999913070358183,0,0,1
456,Ciliary landscape WP4352,0.9154900134915022,0.7635631984251057,0.0674194411573486,"['CTBP2', 'GDI1', 'SSNA1', 'VPS4A', 'COPS7A', 'PSMD8', 'EXOSC4', 'ARHGDIA', 'NEFL', 'RAC1', 'DCAF11', 'NINL', 'RHBDD2', 'DYNLT3', 'H3F3A', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'CD2BP2', 'ANKS6', 'DYNLRB1', 'CALM1', 'COPS8', 'CALM2']",0.9999913070358183,0,0,25
457,One-carbon metabolism WP241,0.9157768102397755,0.47596679489775257,0.04187679657649349,"['AHCY', 'MAT2B']",0.9999913070358183,0,0,2
458,Sphingolipid pathway WP1422,0.9157768102397755,0.47596679489775257,0.04187679657649349,"['PPP2CA', 'SERINC1']",0.9999913070358183,0,0,2
459,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9169239778832459,0.5234402852049911,0.045398349271251644,"['SLC12A5', 'GABRD', 'GABRG3']",0.9999913070358183,0,0,3
460,Notch Signaling WP268,0.9169239778832459,0.5234402852049911,0.045398349271251644,"['JAG1', 'CTBP2', 'DLL3']",0.9999913070358183,0,0,3
461,Type 2 papillary renal cell carcinoma WP4241,0.9169239778832459,0.5234402852049911,0.045398349271251644,"['CDKN1A', 'EGLN2', 'ELOB']",0.9999913070358183,0,0,3
462,ATM Signaling Network in Development and Disease  WP3878,0.9219275313997245,0.550859985451815,0.04477866888845621,"['CDK5', 'H2AFX', 'HSPB1', 'CDK5R1']",0.9999913070358183,0,0,4
463,Ethanol effects on histone modifications WP3996,0.9268713070560374,0.4552338530066815,0.034570709355060354,"['AHCY', 'ALDH1A1']",0.9999913070358183,0,0,2
464,IL17 signaling pathway WP2112,0.9268713070560374,0.4552338530066815,0.034570709355060354,"['CEBPB', 'MAPK3']",0.9999913070358183,0,0,2
465,Trans-sulfuration and one-carbon metabolism WP2525,0.9268713070560374,0.4552338530066815,0.034570709355060354,"['AHCY', 'MAT2B']",0.9999913070358183,0,0,2
466,Glycosaminoglycan degradation WP4815,0.9272655194122021,0.37406182419539497,0.028247400494009835,['IDS'],0.9999913070358183,0,0,1
467,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9272655194122021,0.37406182419539497,0.028247400494009835,['CPT1A'],0.9999913070358183,0,0,1
468,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.9272655194122021,0.37406182419539497,0.028247400494009835,['SUV39H1'],0.9999913070358183,0,0,1
469,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9272655194122021,0.37406182419539497,0.028247400494009835,['SUCLG2'],0.9999913070358183,0,0,1
470,Lipid Metabolism Pathway WP3965,0.9365745930871077,0.4362286562731997,0.028584366632298,"['PRKAR1A', 'FASN']",0.9999913070358183,0,0,2
471,Nucleotide Excision Repair WP4753,0.9377732434116561,0.5232278198840838,0.03361587214125362,"['PCNA', 'CETN2', 'POLD2', 'POLE3']",0.9999913070358183,0,0,4
472,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9389324401660917,0.34909468685069756,0.0219970675067232,['MAPK3'],0.9999913070358183,0,0,1
473,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.9389324401660917,0.34909468685069756,0.0219970675067232,['EZH2'],0.9999913070358183,0,0,1
474,Kallmann's Syndrome WP5074,0.9389324401660917,0.34909468685069756,0.0219970675067232,['PRKCQ'],0.9999913070358183,0,0,1
475,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.941824139099882,0.5449003865596194,0.032659536822968176,"['CACNA2D3', 'PKP2', 'ITGA8', 'ACTB', 'ACTG1']",0.9999913070358183,0,0,5
476,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9429014369348503,0.4757332685140172,0.027970034654505767,"['BSG', 'CXCL17', 'FADD']",0.9999913070358183,0,0,3
477,Amino Acid metabolism WP3925,0.9459958692368392,0.5810019841269841,0.032255531597712495,"['TPO', 'LDHA', 'PKM', 'TDO2', 'ARG1', 'MDH2', 'ALDH1A1']",0.9999913070358183,0,0,7
478,MECP2 and Associated Rett Syndrome WP3584,0.9463705629833782,0.56033658443297,0.030886352656414304,"['GRID1', 'GPRIN1', 'RPS6', 'TAP1', 'FKBP5', 'EZH2']",0.9999913070358183,0,0,6
479,Acute viral myocarditis WP4298,0.9477549273441306,0.5337344572083963,0.02863983102743417,"['ENDOG', 'CYCS', 'ACTB', 'EIF4G2', 'MAPK3']",0.9999913070358183,0,0,5
480,Neural Crest Differentiation WP2064,0.9477549273441306,0.5337344572083963,0.02863983102743417,"['CTBP2', 'MITF', 'CDH7', 'RHOB', 'DLL3']",0.9999913070358183,0,0,5
481,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9477549273441306,0.5337344572083963,0.02863983102743417,"['IL15RA', 'DUSP2', 'DEPTOR', 'STMN1', 'MAPK3']",0.9999913070358183,0,0,5
482,Constitutive Androstane Receptor Pathway WP2875,0.9487285791245602,0.3272484416740873,0.017223912941177352,['HSP90AA1'],0.9999913070358183,0,0,1
483,Integrated Cancer Pathway WP1971,0.9497297258921815,0.4617017930166719,0.023813578403526,"['CDKN1A', 'CDKN1B', 'BAD']",0.9999913070358183,0,0,3
484,Phosphoinositides metabolism WP4971,0.9506377122610403,0.498227289132327,0.02522138316290003,"['PIP4P1', 'MTMR8', 'PLCH1', 'PLCB2']",0.9999913070358183,0,0,4
485,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9524347927983475,0.4026040774370396,0.019620359486603244,"['PRKCQ', 'TGFBR1']",0.9999913070358183,0,0,2
486,mRNA Processing WP411,0.9542560935667649,0.6529332736229287,0.030572426344011742,"['SF3B5', 'SF3A1', 'NCBP2', 'CSTF2T', 'SNU13', 'HNRNPAB', 'LSM7', 'HNRNPK', 'CD2BP2', 'SRSF3', 'SNRPE', 'HNRNPH2', 'HNRNPA1', 'SRSF9']",0.9999913070358183,0,0,14
487,miRNAs involvement in the immune response in sepsis WP4329,0.9569538013882777,0.3079723429888429,0.013550833323597642,['NFKBIA'],0.9999913070358183,0,0,1
488,Toll-like Receptor Signaling related to MyD88 WP3858,0.9569538013882777,0.3079723429888429,0.013550833323597642,['TOLLIP'],0.9999913070358183,0,0,1
489,Male infertility WP4673,0.959510027115546,0.5879356568364611,0.02430085831697276,"['CYP26B1', 'DDX4', 'MSH4', 'HMGA1', 'AHRR', 'HORMAD1', 'TEX15', 'CLU', 'ETV5']",0.9999913070358183,0,0,9
490,One-carbon metabolism and related pathways WP3940,0.961160551645475,0.43597742127153893,0.017270729650308507,"['GPX4', 'GPX3', 'SOD1']",0.9999913070358183,0,0,3
491,Angiogenesis WP1539,0.9638599251529025,0.2908380330464035,0.010705544638848567,['TIMP2'],0.9999913070358183,0,0,1
492,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9638599251529025,0.2908380330464035,0.010705544638848567,['FLT3'],0.9999913070358183,0,0,1
493,TLR4 Signaling and Tolerance WP3851,0.9638599251529025,0.2908380330464035,0.010705544638848567,['NFKBIA'],0.9999913070358183,0,0,1
494,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9654083591594803,0.46489324812998467,0.016366147020836976,"['PCNA', 'CDK5', 'CDKN2A', 'H2AFX']",0.9999913070358183,0,0,4
495,BDNF-TrkB Signaling WP3676,0.9693174697649044,0.36086322095077183,0.011245614682310721,"['TRPC6', 'HRAS']",0.9999913070358183,0,0,2
496,EPO Receptor Signaling WP581,0.969658417415162,0.2755073346768524,0.008488771236899713,['MAPK3'],0.9999913070358183,0,0,1
497,Genes controlling nephrogenesis WP4823,0.969658417415162,0.2755073346768524,0.008488771236899713,['ITGA8'],0.9999913070358183,0,0,1
498,Fragile X Syndrome  WP4549,0.972483163447887,0.5967913071268776,0.01665197916847347,"['EEF1A1', 'GRIP1', 'CPT1A', 'DEPTOR', 'DUSP3', 'PRKAR1A', 'CDKN2A', 'CLTCL1', 'AP2S1', 'AKAP5', 'GABRD', 'AP2M1']",0.9999913070358183,0,0,12
499,Hedgehog Signaling Pathway WP4249,0.9735316194147117,0.34880475129918337,0.009356678579649235,"['EVC', 'GAS1']",0.9999913070358183,0,0,2
500,Energy Metabolism WP1541,0.9738192568710083,0.4023378582202112,0.010673846532463631,"['PPARG', 'PPARA', 'MEF2D']",0.9999913070358183,0,0,3
501,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9738192568710083,0.4023378582202112,0.010673846532463631,"['DEPTOR', 'ATG101', 'FTL']",0.9999913070358183,0,0,3
502,miRNA regulation of p53 pathway in prostate cancer WP3982,0.9745268570799717,0.2617097061442565,0.006752948035610236,['EI24'],0.9999913070358183,0,0,1
503,Sphingolipid Metabolism (general overview) WP4725,0.9745268570799717,0.2617097061442565,0.006752948035610236,['SMPD1'],0.9999913070358183,0,0,1
504,Allograft Rejection WP2328,0.9771836875172177,0.33752424743156834,0.007790273223829393,"['HLA-DQB1', 'C2']",0.9999913070358183,0,0,2
505,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9771836875172177,0.33752424743156834,0.007790273223829393,"['DEPTOR', 'IGFBP5']",0.9999913070358183,0,0,2
506,Sphingolipid Metabolism (integrated pathway) WP4726,0.9786143637696609,0.24922613747190772,0.005387676521765456,['SMPD1'],0.9999913070358183,0,0,1
507,Pathways affected in adenoid cystic carcinoma WP3651,0.9787627531961629,0.4267972012701648,0.009161629438006094,"['CEBPA', 'CNTN6', 'HRAS', 'FOXP2']",0.9999913070358183,0,0,4
508,Interferon type I signaling pathways WP585,0.9824927610053042,0.3735039470333588,0.00659693995867458,"['RPS6', 'RAC1', 'EIF4B']",0.9999913070358183,0,0,3
509,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9847151771104201,0.3647867180698918,0.005618751422984842,"['HRAS', 'MAPK3', 'GRIN2D']",0.9999913070358183,0,0,3
510,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9850034319804155,0.4354742789176331,0.006580083231119459,"['GSK3A', 'RBP4', 'FASN', 'LPL', 'PPARG']",0.9999913070358183,0,0,5
511,Ectoderm Differentiation WP2858,0.9853661225869059,0.5326922901480664,0.007852954436984414,"['SDCBP', 'TOX3', 'ARHGDIG', 'HESX1', 'ST8SIA4', 'TBL1X', 'JAKMIP1', 'CELSR2', 'ZFHX4', 'LY6E']",0.9999913070358183,0,0,10
512,p53 transcriptional gene network WP4963,0.986665582418003,0.3564657267865824,0.0047852384190097885,"['CDKN1A', 'ISG15', 'SLC7A11']",0.9999913070358183,0,0,3
513,Nanoparticle-mediated activation of receptor signaling WP2643,0.9893771686942081,0.2092787177203918,0.0022350247898085688,['HRAS'],0.9999913070358183,0,0,1
514,Hippo-Merlin Signaling Dysregulation WP4541,0.992520982407586,0.42338724266435107,0.0031784212417513367,"['CDH4', 'PRKAR1A', 'FLT3', 'ITGA8', 'HRAS', 'CDH7']",0.9999913070358183,0,0,6
515,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9926195703716129,0.496881452625753,0.0036807983011041085,"['ABCG8', 'GYS1', 'GSK3A', 'THRA', 'RPS6KA2', 'FASN', 'LPL', 'MAP3K8', 'HRAS', 'MAPK3']",0.9999913070358183,0,0,10
516,Splicing factor NOVA regulated synaptic proteins WP4148,0.9931973103675874,0.26810576209239906,0.0018300720759108473,"['EPB41', 'NCDN']",0.9999913070358183,0,0,2
517,Integrin-mediated Cell Adhesion WP185,0.993345758748908,0.41770638107987507,0.0027888080574696036,"['VAV3', 'CAPNS1', 'ITGA8', 'RAC1', 'HRAS', 'VAV2']",0.9999913070358183,0,0,6
518,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9941661828757141,0.26138084632516706,0.0015293132742481346,"['FASN', 'DHCR24']",0.9999913070358183,0,0,2
519,Rett syndrome causing genes WP4312,0.9973111815051181,0.2322395446671616,0.0006252910071882949,"['TBL1X', 'GABRD']",0.9999913070358183,0,0,2
520,Joubert Syndrome WP4656,0.997670405093255,0.31640524730136854,0.0007379559559294899,"['CETN2', 'ANKS6', 'ARL2', 'ZNF423']",0.9999913070358183,0,0,4
521,Integrated breast cancer pathway WP1984,0.9984554352360677,0.43421248696170467,0.0006711877874634768,"['JUN', 'GSK3A', 'GDI1', 'BAD', 'PHB', 'FADD', 'RAC1', 'FAU', 'JAKMIP1', 'TGFBR1']",0.9999913070358183,0,0,10
522,DNA Repair Pathways Full Network WP4946,0.9987839212512043,0.39336968154583835,0.00047865961306471443,"['FEN1', 'NEIL2', 'PCNA', 'CENPX', 'CETN2', 'H2AFX', 'POLD2', 'POLE3']",0.9999913070358183,0,0,8
523,DNA IR-damage and cellular response via ATR WP4016,0.9995737560857443,0.230182447310475,9.813478349780818e-05,"['FEN1', 'PCNA', 'H2AFX']",0.9999913070358183,0,0,3
524,Ciliopathies WP4803,0.999940598907004,0.3488312787080012,2.0721574674618487e-05,"['PKHD1', 'DNAH11', 'BBS10', 'EVC', 'ARL2BP', 'ANKS6', 'CCDC65', 'CCNQ', 'ZNF423', 'CCNO']",0.9999913070358183,0,0,10
525,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999913070358183,0.16096532333645736,1.3992718721803434e-06,"['BBS10', 'EVC', 'DYNLL1']",0.9999913070358183,0,0,3
